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Home Field ADVANTAGE
AS VICE PRESIDENT AND DEAN, JEFFREY S. AKMAN, M.D. ’81, G.M.E. ’85 
LEVERAGES HIS LONG-STANDING CONNECTION TO GW
SPRING 2013
A note from ross HAll 
his time of year, with graduation ceremonies 
taking place and excitement in the air, one 
naturally focuses on the future. Whether we are 
graduating from one of GW’s health sciences or 
Ph.D. programs, completing medical school or 
residency, preparing for the incoming residents, or 
even turning in an annual report as a faculty member — we 
all have our eyes on what lies ahead. For many of us, it is a 
time to celebrate our successes, seize new opportunities, and 
create the future. 
As I reflect on my own graduation from GW’s School 
of Medicine and Health Sciences (SMHS) in May 1981, 
I remember deans Bowles and Keimowitz outlining the 
amazing opportunities that were ahead of us at the time. 
Their optimistic words of wisdom sent us off into a world 
that I now realize is much more unpredictable than I 
imagined that afternoon. In the following years, health 
care would experience unimaginable challenges, such as the 
HIV/AIDS epidemic, as well as major medical advances, 
including robots in the operating room. We would begin to 
realize the promise of genomics and personalized medicine.
Each year, our commencement speakers impress 
upon our graduates the importance of their roles as health 
professionals in society. They reflect upon the incredible 
accomplishments each graduate has already attained. They 
talk about the future, the path to success, and the exciting 
opportunities that await graduates. And as always, our gradu-
ates will transition into a world with new diseases ahead, 
technologies that have yet to be created, and undiscovered 
treatments that will transform the field. 
Yet, this is the most exciting time to be in medicine, 
health care, and biomedical science. There will be challenges, 
of course, in the form of sequestration and cuts to NIH 
funding, along with new models of care and reimbursement 
under the Affordable Care Act — challenges unforeseen 
to classes of the past. However, with full confidence, I can 
assure our graduates that they not only will be prepared for 
the ever-changing health care landscape and scientific land-
scape, but they also have the knowledge, skills, and creativity 
to embrace these challenges and create the future of medi-
cine and health care.
In addition to preparing students for the terrain ahead, 
GW School of Medicine and Health Sciences, as an institu-
tion, is also creating its own future. As you may know, in 
January, I was appointed as the vice president for health 
affairs and dean of the School of Medicine and Health 
Sciences. In this new role, I have traveled extensively, 
discussing potential opportunities, seeking new partner-
ships, and looking for creative ways for alumni and friends 
of the school to get involved with and support SMHS. I have 
benefited enormously from meeting our alumni eager to share 
stories about their GW experiences and to offer input on 
how to navigate our institution through the next decade and 
beyond. With our remarkable 188-year history as a founda-
tion, and with a dynamic constituency of students, residents, 
faculty, and alumni as supporters, I am profoundly grateful 
for the opportunity to lead the GW SMHS during this most 
exciting time to its next level of greatness. 
Sincerely,
JEFFREY S. AKMAN, M.D. ’81, G.M.E. ’85
VICE PRESIDENT FOR HEALTH AFFAIRS 
AND DEAN, SCHOOL OF MEDICINE
AND HEALTH SCIENCES
Facing Our Future
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March Match Up
In the minutes leading up to Match Day, Alex Sims, a fourth-
year medical student at the George Washington University 
(GW) School of Medicine and Health Sciences (SMHS), was 
a mixed bag of emotions — nervous about possibly matching 
with a residency program far from her family, sad to leave the 
place she had called home for the past four years, and, most 
importantly, excited for her future. 
Held on March 15 this year, Match Day is the transition 
point between medical school and residency.
“Match Day is a phenomenal day in the life of a medical 
student,” said Jeffrey S. Akman, M.D. ’81, G.M.E. ’85, 
vice president for health affairs and dean of SMHS. “Our 
students match with some of the leading medical institu-
tions in the country.”
As the noon deadline, when medical students across 
the country get the news on their matches, neared, SMHS 
students filled Ross Hall to celebrate. 
Cheers, tears, hugs, and laughter followed as SMHS 
students received and opened their envelopes from the 
National Resident Matching Program, a nonprofit corpora-
tion established to provide a uniform date of appointment to 
positions in graduate medical education in the United States. 
Fighting back tears, Sims opened her letter. “I feel so 
lucky to get my first choice,” said Sims, who matched in pedi-
atrics–primary care at Children’s National Medical Center in 
Washington, D.C.
Across the room, Siobhan Hartigan and Christal Achille, 
both fourth-year medical students at SMHS, couldn’t stop 
smiling after being matched. Best friends since middle 
school, Hartigan and Achille have always been there for 
each other. “It means a lot to me to have someone I know 
from home be by my side as I go through this process,” said 
Achille. The girls will be apart for the first time in years as 
Achille, a Long Island, N.Y., native, is going back home to 
Stony Brook University Medical Center, where she matched 
in pediatrics. Hartigan matched in urology at the University 
of Pennsylvania.
Children’s National Medical Center in Washington, 
D.C.; Johns Hopkins Hospital in Baltimore, Md.; and 
Vanderbilt University Medical Center in Nashville, Tenn., 
are just some of the leading institutions that SMHS students 
matched with this year. Thirteen students will continue their 
training here at GW . 
>> ON THE WEB
Scan this QR code with any mobile device to view 
a complete list of this year’s SMHS matches.
Christopher D’Avella, M.D. ’13, shares his news that 
he matched in internal medicine at the University of 
Pittsburgh Medical Center, with classmates (from left)
Sagine Berry-Tony and Yevgeniya “Gena” Gora.
Alexandra Sims, M.D. ’13, is moved to tears by the news 
she matched with her top choice, Children’s National 
Medical Center, as classmate Carrie Pinchbeck 
and friend Brandon Roberts look on. 
Daniel O’Neill, M.D. ’13, opens his match letter as his 
father prepares to capture the moment in a photo. 
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Students and residents presented more than 300 posters 
at Medicine and Health Research Day. The scope of 
posters ranged from basic science research to translational 
science projects.
For many presenters, the day is the culmination of years 
of hard work, said Vincent A. Chiappinelli, Ph.D., interim 
associate vice president for Health Affairs and associate dean 
of the GW School of Medicine and Health Sciences (SMHS).
“Medicine and Health Research Day is a celebration for 
the school to highlight the research efforts of our faculty, 
graduate students, residents, and medical students,” said 
Jeffrey Akman, M.D. ’81, G.M.E. ’85, vice president for 
health affairs and dean of SMHS. 
The theme for 2013 was HIV/AIDS. “We decided to 
focus on HIV/AIDS because our faculty has been at the 
forefront of HIV/AIDS research for decades,” added Akman.
Gary Simon, director of the division of infectious 
diseases, vice chair of the Department of Medicine, Walter 
G. Ross Professor of Medicine and of Microbiology and 
Tropical Medicine, and professor of biochemistry and molec-
ular biology at SMHS, delivered the first keynote address. 
Simon shared his personal journey with HIV/AIDS — 
from researching its causes and prevalence in the District to 
experimenting with different treatment drugs to uncovering 
new preventive measures. 
Alan Greenberg, M.D. ’82, professor and chair of the 
Department of Epidemiology and Biostatistics at GW’s 
School of Public Health and Health Services, and director of 
the District of Columbia Developmental Center for AIDS 
Research (D.C. D-CFAR), delivered the second keynote 
address.
Greenberg gave an overview of HIV/AIDS epidemiology 
and prevention and addressed the HIV/AIDS work that is 
currently being done in Washington, D.C.  
Medicine and Health Research Day
>> ON THE WEB
Scan this QR code with any mobile device to 
view a complete list of the 2013  Research Day 
award winners.
Third-year Ph.D. student Kristin Ceniccola 
presents her research poster at this year’s Research Day.
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Renowned HIV/AIDS Researcher 
Joins GW
The George Washington University (GW) School of 
Medicine and Health Sciences (SMHS) is pleased to 
announce that HIV/AIDS researcher Douglas F. Nixon, 
M.D., Ph.D., will be joining the faculty on Oct. 1, 2013, as 
the Ross Professor of Basic Science Research and chair of 
the Department of Microbiology, Immunology, and Tropical 
Medicine (MITM).
Nixon has pursued immunovirology research for more 
than 25 years; his studies have included clinical research, 
human immunology, basic virology, and molecular biology. 
Over the past two decades, he has focused on the cellular 
immune response to retrovirus infections and has published 
extensively on this topic. Nixon gained recognition for 
publishing the first identification of an HIV-specific cyto-
toxic T cell CTL epitope, in the journal Nature.
“Dr. Nixon is going to be a great addition and an 
inspiring leader for the department’s faculty, students, and 
staff. His expansive research portfolio and vast expertise 
will enable the department to maintain its highly regarded 
reputation and expand its signature programs,” said Jeffrey S. 
Akman, M.D. ’81, G.M.E. ’85, vice president for health affairs 
and dean of SMHS.
Nixon’s research is funded through grants from the 
NIH, including an NIH Merit Award, AmfAR, and the 
Gates Foundation. He is the chair of the NIH AIDS 
Vaccine Research Subcommittee, is a scientist of the 
Elizabeth Glaser Pediatric AIDS Foundation, delivered the 
Distinguished Science Lecture in 2009 at the NIH Rocky 
Mountain Laboratories, and is a member of several leading 
professional organizations.
He was named as one of the 2012 POZ 100, which is an 
elite group of scientists, researchers, advocates, politicians, 
and celebrities who are recognized by POZ Magazine for their 
significant contributions to speeding up the end of AIDS. 
“Infectious diseases are a global problem, and also 
manifest at a local level. In Washington, D.C., the prevalence 
of HIV infection is one of the highest in the nation,” said 
Nixon. “By studying infectious diseases at a local and global 
level, research at MITM, in very close collaboration with 
colleagues throughout GW, can contribute to new discoveries 
for biomarkers, diagnostics, and vaccines, and novel treat-
ments for these diseases.”  
GW Heart and Vascular Institute 
Forges Public Health Partnership
The George Washington University (GW) Heart & Vascular 
Institute and The Wireless Foundation, in partnership with 
the D.C. Fire and Emergency Medical Services, announced 
an innovative new public health initiative. The collaboration 
is designed to improve cardiac care in the nation’s capital. 
Through this initiative, D.C.-area ambulances have been 
equipped with technology that enables rapid, wireless trans-
missions of EKGs to be sent to both the on-call physician’s 
wireless device and tertiary care hospitals. 
“This technology will allow the medical team to make 
decisions early, in many cases before the patient even 
arrives at the hospital, and should significantly improve 
the outcomes of patients,” said Jonathan Reiner, M.D., 
professor of medicine at GW’s School of Medicine and 
Health Sciences.  
Advocating Her Way to Wellness 
and a Better Education
Ask medical students what is most important to them and 
you get similar responses — support for their education 
and overall well-being. That’s certainly the case for Amy 
Waldner, a third-year medical student at GW’s School of 
Medicine and Health Sciences (SMHS), who will use her new 
leadership role to advocate for her fellow medical students. 
As of January, Waldner is the GW student representative to 
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the Organization of Student Representatives (OSR), and she 
was elected as a national delegate to the OSR Administrative 
Board. Founded to represent medical students nation-
wide, the OSR ensures that students actively participate in 
directing their education, while working with the Association 
of American Medical Colleges (AAMC) to improve the 
nation’s health. Waldner will represent students in the 
AAMC by providing feedback on the programs and services 
that are sponsored by the organization, then disseminating 
that information to her fellow students.
The key to success in Waldner’s new role is keeping 
current. “I have to stay up-to-date on everything from new 
recommendations for applications to residency, to away rota-
tions, to national residency matching programs, to MCAT 
changes,” she said. Most importantly, her role is to stand up 
for students, said Waldner.
In her new position, Waldner will work closely with 
Scott Schroth, M.D., M.P.H., associate dean for administra-
tion at SMHS and chair of the Group on Student Affairs 
(GSA) Steering Committee for the AAMC.   
Student wellness is a major initiative that falls under the 
student affairs umbrella, said Schroth and Waldner. “We are 
trying to focus not just on emotional and mental health well-
ness, but also physical and spiritual wellness,” said Schroth. 
Waldner echoes Schroth’s desire to ensure that students’ 
needs beyond academics are met. “It’s my job to make sure 
that students know what resources are available in terms of 
wellness,” said Waldner.
Waldner is also learning how to advocate for herself and, 
most importantly, her future patients. “In a sense, patients 
are voiceless. You need to know how the legislative system 
operates, as well as the different points of entry for advo-
cating on behalf of your patients.”   
GW PA Students Support Clinical 
Officer Training Program in Rwanda
The GW Physician Assistant (PA) program and the 
Rwandan Embassy have joined forces to bring lab coats, 
training supplies, and textbooks to Rwandan health 
professional students.
Lisa Alexander, Ed.D., M.P.H., P.A. ’79, director of 
GW’s PA program, served as a Fulbright senior specialist 
to the Ministry of Education in Rwanda in 2009–10 to 
determine how best to meet the existing health workforce 
shortages, especially in rural primary care. After completing 
a feasibility study, she collaborated with faculty at the Kigali 
Health Institute to develop the curriculum. Even with these 
resources, and despite several attempts to secure additional 
government or international monies, the funding for the 
program was severely limited. 
The Clinical Officer program, however, has persevered 
through these challenges and has been able to accept its 
first class of students in 2012. It is in the process of training 
its first cohort of 150 students to function as the country’s 
newest health professionals.   
No Stone Unturned
In the United States, one in 10 men and one in 14 women has 
had a kidney stone. Jeremy Brown, M.D., associate professor 
of emergency medicine at the GW School of Medicine and 
Health Sciences, has received a grant to explore new ways to 
treat kidney stones. 
Brown received a four-year, $4.2 million cooperative-
agreement research project grant from the National 
Institutes of Health and the National Institute of Diabetes 
and Digestive and Kidney Diseases. His research project 
will enroll patients with kidney stones in three emergency 
departments (EDs), including the ED at GW Hospital, 
and randomize them to either an active medication called 
Tamsulosin or a placebo. 
Brown believes treatment with Tamsulosin may 
help patients pass their kidney stones faster and with 
fewer complications.  
Headlining Hedgehogs
Many researchers believe that the Hedgehog (Hh) signaling 
pathway, which transmits information to embryonic cells for 
proper development and is important for regeneration, may 
actually regulate cell-to-cell adhesion and segregation — but 
there isn’t any evidence it’s true. Xiaoyan Zheng, Ph.D., 
assistant professor of anatomy and regenerative biology at 
GW’s School of Medicine and Health Sciences, is working 
to change that. With a $747,000 grant from the Eunice 
Kennedy Shriver National Institute of Child Health and 
Human Development at the National Institutes of Health, 
Zheng will focus on identifying the mechanism involved in 
this process.
“This is a very fundamental question, but a very 
important question, especially in the process of cancer devel-
opment,” said Zheng. “I’m trying to understand the basic, 
but very important question of how the Hh signal defines 
cell-to-cell interaction, which is what I am going to focus on 
with this grant.”
The project, titled “Hedgehog-mediated regulation of 
cell adhesion,” will be funded over a three-year period.   
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His pleased parents and grandparents sit with him at the 
kitchen table, filled with pride and expectation. His grand-
mother, Bubbe Rose, reaches into her ample pocketbook and 
pulls out an assortment of pill bottles, perhaps 10 in all, and 
asks: “So, Jeff, do you think I’m on the right medications?”
Akman laughs as he thinks back to the scene. “I’d been 
in school for three months. But it struck me that it’s all part 
of how people see you and treat you as a doctor, and it’s part 
of the evolution of your own identity.”
So, years later, when a student approached Akman, by 
then director of medical student education in psychiatry 
and an assistant dean at GW’s School of Medicine and 
Health Sciences (SMHS), and said that he’d figured out that 
medical school was just a glorified vocational institution, 
Akman encouraged him to reconsider. “You don’t realize how 
you’ve evolved in your identity and your sense of yourself,” he 
recalls telling the student. “I wanted him to understand the 
developmental process that students go through when they 
become physicians, how their confidence and their profes-
sionalism evolves.”
Akman’s own identity is inextricably tied to SMHS, 
where he has been a student (M.D. ’81); a resident (G.M.E. 
’85); a faculty member; an administrator; the Leon M. 
Yochelson Professor and Chair of the Department of 
Psychiatry and Behavioral Sciences; the interim vice presi-
dent for health affairs and dean; and, as of January 2013, 
the Walter A. Bloedorn Chair of Administrative Medicine, 
vice president for health affairs, and dean. He arrived at the 
school just four years after Ross Hall opened in 1973, and his 
long experience with SMHS is a huge advantage in his new 
role, he says.
“I know the DNA of the school. I know it from so many 
different perspectives,” Akman says. “I know the culture and 
the history, and when I think about my role as dean, all my 
experiences are relevant.” During a recent trip to California, 
Akman spoke with a 1970s-era alumnus who expressed the 
hope that SMHS remains as supportive of its students today 
as it had been in his experience. “I replied that not only am 
I a product of that culture of collaboration, cooperation, 
teamwork, and support, I feel like I’m the guardian of it,” 
says Akman.
This does not mean that the dean’s stewardship equates 
to running in place. At a town hall meeting after he took 
office, Akman presented an ambitious list of priorities, 
including increasing the number of scholarships; maintaining 
tuition affordability; re-examining and revising the medical 
education curriculum; helping GW advance as a top-tier 
research university; enhancing diversity at SMHS; enlarging 
the school’s footprint internationally, especially in China; 
finishing the renovations to Ross Hall and planning for a 
new building; increasing space for teaching and labs at GW’s 
Virginia Science and Technology Campus in Ashburn; and, 
finally, revising the strategic plan as soon as new leadership 
appointments are finalized. An expansive agenda, to be sure. 
At the same meeting, Akman commented that it was 
“kind of nice” to have a psychiatrist in the dean’s office. 
Although the remark drew knowing laughter, he was only 
half joking. “As a psychiatrist, you’re trained to deal with a 
range of personalities and group dynamics. You’re trained to 
listen carefully,” he says. “You have to be a leader and also to 
communicate your vision and priorities, but ultimately if you 
want change to occur, you have to get buy-in — and being a 
psychiatrist helps with that.”
When the search process began, says GW President 
Steven Knapp, he and Provost Steven Lerman were looking 
for a candidate who ideally had “the leadership and people 
skills necessary to serve as an ambassador for the university.”
hanksgiving break, 1977. Jeffrey scott 
Akman, union leader’s son and Duke 
University graduate, returns to his family’s 
Baltimore home having just completed his first 
few months of medical school at the george 
Washington University. 
T
“I know the DNA of the school. I know it from so 
many different perspectives,” Akman says. “I know 
the culture and the history, and when I think about 
my role as dean, all my experiences are relevant.”
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“This is a particularly complex role,” explains Knapp. 
“Not only does the position entail all of the responsibilities 
and requirements of academic leadership as dean of a profes-
sional school, but also the vice president for health affairs 
serves as the liaison between the GW Hospital, the GW 
Medical Faculty Associates, Children’s National Medical 
Center, and the VA.”
In the area of building consensus, Akman has had some 
strong influences in his life. As the son of a union leader, he 
holds vivid memories of union halls packed with hundreds of 
workers, and watching as his father spoke, persuading them 
to accept or reject a contract. When Akman first became 
interested in medicine as an undergrad at Duke, his father’s 
cousin, Leonard Akman, M.D. ’43, a cardiologist who gradu-
ated from GW, gave him his first microscope. There was 
also former Dean Robert Keimowitz, M.D., who encouraged 
his choice of psychiatry, as well as other faculty members, 
including the late Winfield Scott, Ph.D., who mentored 
Akman and in 1988 recommended him for the board of the 
National Lesbian and Gay Health Foundation.
Akman was living in one of the hardest-hit areas of the 
HIV/AIDS epidemic in the early 1980s, and his work with 
the then fledgling Whitman-Walker Clinic and his treat-
ment of HIV/AIDS patients is an enduring part of a medical 
career that has led to numerous honors, such as his selection 
by Washington, D.C., Mayor Vincent Gray to serve on the 
city’s Commission on HIV/AIDS. Akman also sees HIV/
AIDS as an important research area on which to build; he 
recently hired Douglas Nixon, M.D., Ph.D., an internation-
ally recognized HIV/AIDS researcher from the University of 
California at San Francisco, to chair the SMHS Department 
of Microbiology, Immunology, and Tropical Medicine.
He vividly recalls his early experiences as a clini-
cian facing the burgeoning epidemic in 1984. Akman had 
a patient, a man in his 20s who was a photographer, who 
announced that he was suicidal. “He came into the hospital 
with an IV in his arm, as he was receiving intravenous treat-
ments at home. He could have committed suicide if he really 
wanted to,” recalls Akman. “I learned that when patients say 
they want to die, frequently what they mean is that they want 
to live, and they are searching for hope. Despite his terminal 
illness, he was able to work through the pain and many of the 
losses he was dealing with. I learned a great deal from him.”
Akman has served as a willing role model for LGBT 
students and those unsure of their sexual orientation. His 
sense of inclusiveness prompted his friend and colleague 
Seymour Perlin, M.D., GW professor emeritus of psychiatry 
and behavioral sciences, to say that Akman “is an example 
of what every mentor or tutor hopes will emerge from their 
guidance and training. He possesses the gift of bringing 
people together.”
That gift will help Akman in his service to the school’s 
development office, which keeps him busy meeting alumni. “I 
truly value alumni and the role they play in the school; among 
other things, I’m prominently including them in special 
events such as our white coat ceremonies and graduations,” 
he says. One of Akman’s goals in the near future is to secure 
a gift for the naming of SMHS, which will go a long way in 
securing the school’s future.
“Set the bar high for medical and health sciences educa-
tion, and our students will get there,” is how he expresses 
his education philosophy. Akman has set lofty heights for 
his own stewardship, and there is every expectation they will 
be reached.  
 
Akman shares the excitement and joy of match day 
with members of the SMHS Class of 2013.
Keeping it all in perspective, Akman shares a light-hearted 
moment with classmates during medical school.
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awrence Deyton asks that you call him by his nick-
name, Bopper. After all, it’s what his family, friends, 
and colleagues have always called him. “I didn’t 
even know about the name Lawrence until I got 
to junior high school,” insists Deyton. “My mother 
and older sister sat me down and told me that Bopper was a 
nickname given to me as an infant and the name just stuck.” 
Whatever you call him, returning to the George Washington 
University (GW) is returning home for Lawrence “Bopper” 
Deyton, M.D. ’85, who has joined GW’s School of Medicine 
and Health Sciences (SMHS) faculty as a clinical professor of 
medicine. He will also serve as a professor of health policy at 
the GW School of Public Health and Health Services. 
Driven by his passion for a healthier United States, 
Deyton brings to the university more than 30 years of experi-
ence in federal public health, health policy, health system 
administration, and clinical research. Deyton held leadership 
positions at the National Institute of Allergy and Infectious 
Diseases at the National Institutes of Health for 11 years, and 
served as the chief public health and environmental hazards 
officer for the U.S. Department of Veterans Affairs’ Veterans 
Health Administration. And in the 1970s he co-founded the 
Whitman-Walker Clinic in Washington, D.C. 
More recently, as the first director of the Center for 
Tobacco Products at the U.S. Food and Drug Administration 
(FDA), Deyton led the creation of the science, regulatory, 
and enforcement foundation for implementing the Family 
Smoking Prevention and Tobacco Control Act. The act was 
signed into law by President Barack Obama on June 22, 2009, 
becoming one of the president’s first major public health 
accomplishments. Deyton led the implementation of rules 
and regulations that prohibited marketing tobacco products 
to children and adolescents; prohibited the manufacture and 
sale of cigarettes with fruit or candy flavors; banned the use 
of misleading descriptors (“light,” “low,” or “mild”); enacted 
requirements for disclosure of tobacco product ingredients to 
the FDA, and set the scientific standards for the introduction 
of new or modified-risk tobacco products. 
Being back at GW, Deyton is most excited about 
engaging with students, trainees, and faculty. “I want to help 
Bopper Comes 
Back to gW 
by LAuRA OTTO
mold medical students into highly trained clinicians who 
can also be leaders in health policy and public health,” says 
Deyton. Last summer, Jeffrey S. Akman, M.D. ’81, G.M.E. 
’85, vice president for health affairs and dean of SMHS, asked 
Deyton to serve as the keynote speaker for the M.D. White 
Coat ceremony. Honored by Akman’s invitation, Deyton 
says the experience transformed him. “Walking up to that 
podium in Lisner Auditorium, the very place where I took my 
Hippocratic Oath, was an extremely powerful moment for 
me,” he recalls. 
So much has changed at GW since those days when he 
was a medical student. The biggest difference, according 
to Deyton, is the university’s growth. “When I came to 
GW, where the GW Hospital is now was a parking lot and 
the space that was the GW Hospital is now Whole Foods,” 
recalls Deyton. 
There is no doubt that Deyton is excited to be back in 
the classroom. “Hopefully GW students can benefit from my 
experiences in medicine, public health, and health policy,” 
he said. “I want to encourage our trainees and faculty to take 
full advantage of GW’s status as ‘neighbor’ to the White 
House and the decision makers in the federal agencies,” said 
Deyton. “It is great to be back home.”  
L
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n the film 50/50, based on a true story, a 27-year-
old writer is blindsided by a cancer diagnosis and 
struggles with the disease, as well as the bewilder-
ment of his friends and family. James L. Scott, M.D., 
former dean of GW’s School of Medicine and Health 
Sciences (SMHS) and a professor in the Department of 
Emergency Medicine, teaches this movie in a film and 
medicine course. “It portrays living with cancer in a way we 
don’t normally think about, with a young man dealing with it 
through black humor, with friends making fun of it, living with 
it in ways that wouldn’t occur to most people,” says Scott.
And it fits in with the goals of humanities education at 
SMHS, which is aimed at using the arts to deepen the under-
standing of the human condition. Or, to put it another way, 
adding the essence of Euripides to the ethos of Hippocrates.
Vice President for Health Affairs and Dean of SMHS 
Jeffrey S. Akman, M.D. ’81, G.M.E. ’85, an avid supporter of 
the program begun by Scott in 2005, and himself a former 
English major at Duke University, says: “I think the arts and 
humanities give us particular insights into the human condi-
tion that are relevant to being a physician. I want to support my 
students, residents, and faculty so that they think about people 
in a complex way, and arts help us to do that. I think that’s what 
drives people to medicine — the notion of humanity.”
GW holds a unique and prominent place in medical 
humanities education in the United States. Although a 
majority of medical schools offer some courses in medical 
humanities, only a relatively small percentage offer as robust 
a program as SMHS, according to Therese Jones, Ph.D., 
interim director of the Center for Bioethics and Humanities 
Hippocrates and the essence of euripides
Medical humanities education illuminates the human condition, creates more effective clinicians
I
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at the University of Colorado, Denver. And the emphasis at 
GW is growing. 
“Medical humanities” is typically defined as an interdis-
ciplinary field of humanities (literature, philosophy, ethics, 
history, and religion), social science (anthropology, cultural 
studies, psychology, sociology), and the arts (literature, 
theater, film, and visual arts) and their application to medical 
education and practice. Apart from providing insight into the 
human condition, studying literature and the arts helps to 
develop and nurture skills of observation, analysis, empathy, 
and self-reflection — skills that are essential for humane 
medical care.
Linda Raphael, director of the medical humanities 
track curriculum at SMHS, emphasizes the interdisciplinary 
nature of the program. “When any discipline sees itself as 
separate from all other things, it tends to suffer,” she says. 
“Medical education is very vigorous and demanding. The 
humanities offer an opportunity for students to think and 
talk about what they’re doing in a different language and 
through different perceptions. It takes them a little back into 
the world they’ve come from.”
At GW, medical humanities electives are offered in the 
first, second, and fourth years. In the third year, Raphael 
leads one to three sessions in all of the clerkships — psychi-
atry has three, for example. So even if a student chooses 
not to take any electives, he or she will attend humani-
ties sessions in the clerkship year. “By the fourth year, the 
number of students exposed to classes in medical humanities 
is at least one-third of the 170 students in each class,” she 
says. There are also those who choose the humanities track 
for all four years, although this cohort is small. 
Raphael, who teaches a course on graphic literature 
involving medicine called “Commix,” recalls a neurology 
track student who was particularly moved after viewing a film 
meant to stimulate discussion about the distinction between 
sympathy and empathy. “She said it meant a lot to her to have 
an opportunity to talk about these things,” Raphael says.
Another innovation at SMHS is a Theater in Medicine 
program, developed by Charles Samenow, M.D., assistant 
professor of psychiatry and behavioral sciences and director 
for medical student education, and GW visiting professor 
Jeffrey Allen Steiger, who directed a theater program at the 
University of Michigan. A team of actors, some of whom 
have a background in health care, use common issues such 
as personal relationships, stress, and competitiveness among 
practitioners to highlight theories of professionalism.
One performance, called “Milestones,” is a dynamic, 
interactive multimedia production focused on professionalism, 
burnout, and disruptive behaviors. Samenow believes that 
information delivered through the medium of theater — “a safe 
learning environment” — resonates with students and faculty, 
and makes lessons on communications, conflict resolution, and 
teamwork more vivid and, often, longer lasting. Feedback from 
students and professionals has been very positive. 
Psychiatrist and philanthropist Assad Meymandi, 
who received his M.D. from GW in 1962, has been a vocal 
supporter of humanities education at his alma mater. “The 
most important thing for me is to bridge the gap between 
basic sciences and the humanities and the arts,” he says. “I see 
so many humanists who don’t know anything about science 
and so many scientists who know nothing about the humani-
ties. I want to bring the two bodies together.” Meymandi says 
he’d love to add a course to the humanities curriculum about 
“what it means to be a human.” 
Humanities education at GW is not restricted to medical 
students. Christopher Bayne, a urology resident, is chair 
of the Arnold P. Gold Humanism Honor Society chapter 
(see page 32). “The Gold Foundation and others like it are 
trying to bring the human element back into what is almost 
algorithmic care,” he explains. “Medicine used to be a very 
personal interaction; now it’s not.”
Akman spends significant time speaking to alumni and 
potential donors about supporting the humanities educa-
tion program. He is proud of the humanities history at the 
school, which he says actually began with popular professor 
Frank N. Miller, B.S. ’43, M.D. ’48, GW professor emeritus 
of Pathology, who originated a Medicine in Literature 
course way back in 1967.
Akman himself teaches a course with Raphael. A theater 
buff, he was momentarily overwhelmed with ideas when 
asked what play he would teach. “Angels in America by Tony 
Kushner,” he reasons. “It deals with HIV/AIDS, and he 
builds an epic play around a medical illness.
“If I could have medical students see one play, that 
would be it.”  
Samenow believes that information delivered 
through the medium of theater — “a safe learning 
environment” — resonates with students and 
faculty, and makes the lessons on communications, 
conflict resolution, and teamwork more vivid and, 
often, more permanent. 
>> ON THE WEB
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n the summer of 1996, the scientific community was 
stirring with the news of the birth of Dolly the sheep 
— the first mammal to be cloned from an adult cell. 
Shawneequa Callier was still a high school student in 
Queens, N.Y., at the time, but she was already captivated by 
the ethical concerns that arose from this breakthrough.
During her freshman year at Princeton University, 
Callier enrolled in her first bioethics course. It was taught 
by renowned political scientist and philosopher Amy 
Gutmann, Ph.D., who now serves as chair of the Presidential 
Commission for the Study of Bioethical Issues and president 
of the University of Pennsylvania. “My most vivid memory 
of any college professor is of Dr. Gutmann,” recalls Callier. 
“She eloquently presented us with case studies and thought 
experiments that trained us to think about transparency, 
accountability, and ethical decision making. I continue to 
admire her as an instructor and thought leader.”
Shawneequa Callier, J.D., M.A., assistant professor 
in the Department of Clinical Research and Leadership 
at the George Washington University School of Medicine 
and Health Sciences (SMHS), has since dedicated herself 
to the study of the ethical, legal, and social implications of 
human genome research. She says she “fell in love with the 
field” as a graduate student interning at the World Health 
Organization’s Human Genetics Programme in Geneva 
(before that, Callier studied bioethics at Monash University 
in Australia), where she had the opportunity to review inter-
national guidelines related to genetic research and the ethical 
conduct of such research.
After stops at Georgetown University Law Center and 
the Case Western Reserve University Center for Genetic 
Research Ethics and Law, Callier joined the SMHS faculty 
in the spring of 2011. She currently teaches online health 
sciences courses in bioethics and health care law. Callier, a 
self-proclaimed fan of social media, enjoys teaching online. 
She utilizes discussion boards and reflection journals, and 
says that “unlike in a classroom where five to 10 students 
might speak all the time, I know what’s going on in every 
single student’s head.”
She recently built a wiki (a website that enables users 
to add or change content) for her bioethics class and asked 
her students, many of whom are adult professionals already 
Comparative Speaking
Clinical Research and Leadership Professor Shawneequa Callier, J.D., M.A.,  
weighs in on the implications of human genome research
by KRISTIN HubING 
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working in health sciences, to contribute to a list of issues 
they would want a patient to understand before donating 
DNA to a biobank. “Teaching in a classroom is great too,” 
Callier says, “but these students are leading very busy lives. 
They want to get a degree while they’re also being leaders at 
the office, and this is a great way to allow that.”
When she’s not teaching, Callier is immersed in her 
research. As a co-investigator on a grant funded by the 
National Human Genome Research Institute at the National 
Institutes of Health, she addresses the ethical, legal, and 
social issues raised in personalized medicine within the 
context of comparative effectiveness research (CER). 
“There is a potential conflict between CER and personal-
ized medicine,” Callier explains. “CER aims to identify the 
most efficient and effective strategies for treating the average 
patient suffering from a particular disease, but personalized 
medicine focuses on medical interventions tailored to fit each 
person’s unique genetic profile. Ideally, the two will evolve 
together so that providers can place patients into subgroups 
and then pinpoint the most cost-efficient strategies for each 
person within those subgroups.” Two graduate students 
from GW’s School of Public Health and Health Services, 
Rachel Simpson and Monica Gonzalez, assist Callier with 
her research on this grant, as well as her work as one of three 
principal investigators evaluating providers’ use of race and 
genetics in medical care.
According to Joseph Bocchino, Ed.D., M.B.A., senior 
associate dean for health sciences, Callier’s work is essential, 
given the important role that bioethics plays in how health 
care will be shaped and delivered in the future. “Dr. Callier’s 
contributions to SMHS will be particularly important as the 
school engages in more health outcomes and comparative 
effectiveness research,” Bocchino says. “Also, her passion for 
this field is now being transferred through her classroom to 
the next generation of health practitioners and researchers.”
Callier is deeply concerned about gaps in research that 
limit our understanding of genetic contributions to disease 
globally and therefore our understanding of the role of 
rare mutations domestically. This unease prompted her to 
co-author an article titled “Why personalized medicine 
will fail if we stay the course,” which was published in the 
November 2012 issue of the journal Personalized Medicine. 
Callier’s other recent publications include “GINA and 
preemployment criminal background checks,” which is a 
Hastings Center Report piece about the Genetic Information 
Nondiscrimination Act, and a target article in The American 
Journal of Bioethics about whether universities should be 
allowed to facilitate educational DNA testing.
Currently, Callier is also collaborating with investiga-
tors at the National Human Genome Research Institute 
and at universities in Africa who share her interest in the 
just and equitable distribution of the benefits of genomic 
research. “I’m co-authoring a manuscript now with another 
Georgetown Law alumna who lives in Nigeria. We’re evalu-
ating legal issues raised by genomic research in Nigeria and 
assessing the role of local laws and customs,” she says. 
Callier sees herself evolving in the genetic research 
world, but can’t imagine ever leaving it. She is currently 
following the 
Maryland v. King 
Supreme Court case, 
which addresses 
whether the Fourth 
Amendment 
allows states the 
right to collect 
and analyze DNA 
from those who 
have been arrested 
and charged with 
serious crimes. “I’m 
collaborating with 
a colleague at the 
Center for Research 
on Genomics and 
Global Health on a paper about what it takes to qualify an 
expert witness on genetic testing,” Callier says. “Given the 
rapid advancement of genomic technology and the simulta-
neous controversies raised by the regulation and reliability of 
genetic testing services, debate about the utility, validity, and 
safety of gene-based, medical decision making will eventually 
find its way into the courtroom.”
When it comes to the regulation of genetic research, 
Callier says she is a fan of information, education, and 
dialogue. “I don’t think we can really know what the regula-
tions should be until we have a conversation with the people 
who are going to be impacted by those regulations,” she 
says. “Experts who study the consequences of these tech-
nologies should interact with the people who are going to 
be affected by the technologies. We have to protect the 
informed consent and the health and safety of every single 
person we involve in research, but we want to have an idea of 
the community’s needs and we want to make sure we address 
them as we pursue research.”
Throughout it all, Callier remains grateful for the 
support of her colleagues at GW. “I’ve moved around quite a 
bit, and this is one of the first times where I feel like I’m in 
the right environment,” she says. “And that’s kind of cool.”  
>> ON THE WEB
Scan this QR code with any mobile device for 
related content — available online below the story.
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ally A. Moody is a lab rat. She works with 
frogs in service to the world’s mammals, 
especially the two-legged kind. If her 
research at GW reaches its full potential, 
it will mark a significant breakthrough in 
neural regeneration through the manipula-
tion of stem cells.
Sally Moody, Ph.D., a professor of 
anatomy and regenerative biology at the 
George Washington University School of Medicine and 
Health Sciences, is currently exploring the cascade of interac-
tions that instruct lineages to give rise to the frog nervous 
system. In collaboration with fellow GW professor and 
GW Institute for Neuroscience Director Anthony-Samuel 
LaMantia, Ph.D., Moody is trying to determine whether 
what she has learned about manipulating a gene in the frog 
embryo is applicable to mouse embryonic stem cells. 
The 60-year-old personable, tattooed (yes — more on 
that later) former music major, who grew up on a dairy farm 
in upstate New York, is celebrating the 30th anniversary of 
her lab, which she began at the University of Virginia as an 
assistant professor. To fully appreciate Moody’s dedication 
to her lab, let’s reflect on the story of Max Mandelbaum. 
Last year, Mandelbaum, an eager GW freshman from the 
Philadelphia suburbs, signed up for a stem cell course that 
Moody was offering. Unfortunately, he was the only enrollee, 
so Moody offered him a choice of dropping the course or 
taking a one-on-one seminar with her each Wednesday.
Mandelbaum was amazed. “I think most professors 
would have just canceled the course,” he said later. 
One Wednesday, Mandelbaum found Moody’s office 
door locked. “I had simply forgotten,” she explains, “so he 
tracked me down in the lab.” Moody explained she was 
working with frog embryos and the student was enthralled. 
And that’s how Max Mandelbaum became one of three 
undergrads now working for credit in her lab. “I’m trying 
to get him a grant so he can work in the lab this summer,” 
Moody says. “He’s very gung-ho.” 
Mandelbaum says his career path has changed. “I was 
originally focused on med school,” he says, “but the more I 
work in her research lab, the more I’m thinking of getting a 
Ph.D. and pursuing my own research.”
Moody spends a lot of time with her undergrads, teaching 
them how to do research and working with them at the bench. 
“I really enjoy this,” she says. “I had a similar experience as 
an undergrad doing independent research — once I figured 
out I wanted to do biology.” In fact, if not for her wanting 
to escape rural New York and having a lack of confidence 
in her own musicianship, the world might have lost an 
eminent researcher.
Her desire for independence led Moody to leave high 
school after her junior year after being accepted early by 
Goucher College in suburban Baltimore. Halfway through 
her second year, Moody says, she “realized there was no way 
I was ever going to make a living as a music major because 
I wasn’t that good.” The longtime self-described “science 
nerd” switched to biology and again graduated after only 
three years. Seeking financial independence, Moody finally 
landed a job as a lab tech in the anatomy department at the 
University of Maryland School of Dentistry. “They taught 
me to do histology and I loved it,” she says. “And they asked 
me if I wanted to get a master’s because they saw how inter-
ested I was.” 
Moody did research in neuroscience under the tutelage 
of Richard Meszler, Ph.D., and her career path exploring 
the nervous system was launched. She earned her Ph.D. in 
neuroscience from the University of Florida and served a 
JuMpiNG tO SOlutiONS
Researcher Sally Moody uses frog embryos 
to clear the knowledge gap in neural regeneration 
by STEVE GOLDSTEIN
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postdoctoral fellowship at the University of Utah until 
1983. She then went to the University of Virginia and 
served on the faculty of the Anatomy and Cell Biology 
Department, the Department of Neuroscience, and the 
Developmental Biology program. She came to GW as a full 
professor in 1994.
So what goes on in her lab? Moody and her team are 
working on two grants from the National Science Foundation 
and the National Institutes of Health. Working with a gene 
called FoxD4 in Xenopus laevis, the African clawed frog, 
Moody and her team want to influence a cell that normally 
makes gut or skin to instead make nervous system. “What 
we’re trying to do is understand how an embryonic cell makes 
the decision to become a neuron,” she says. “It doesn’t have to 
do with the frog’s nervous system; the frog is just the medium 
in which it’s easiest to do the experiments. When they start 
out, embryonic cells are pluripotent — that is, they can make 
lots of different tissues. So it’s those early decisions we’re 
trying to parse out, really looking at a network of genes and 
how they interact to cause this conversion of a cell that can 
make anything to a cell that can only make nervous system. 
That’s pretty cool.” 
The collaboration with LaMantia’s lab “grew out of our 
shared interest in the early steps of specifying neural stem 
cells,” says LaMantia. “Sally had done pioneering work on 
a family of genes, the forkhead or Fox genes, that she had 
shown clearly were key for neural stem cell identity in the 
frog. My colleagues and I found that the mouse equivalent 
of one of these genes had a dramatic increase in expression 
just as the forebrain — the part of the embryonic brain that 
will make all of the regions that do the ‘heavy lifting’ of 
cognition, learning, and memory — becomes distinct as a 
defined region. I think we really have been able to establish 
an approach that will allow us to begin to sort out just what 
the ‘switches’ are that direct a stem cell to become a neural 
stem cell.” 
Also in Moody’s lab, research scientist Bo Yan, 
M.D., Ph.D., professor of Anatomy and Cell Biology and 
of Genetics, is working on a two-year grant from NIH’s 
National Institute of Dental and Craniofacial Research, for 
its project on identifying novel genes involved in neural tube 
and craniofacial birth defects. 
If the research gods smile upon Moody’s work, scien-
tists will be able to control development of embryonic cells, 
whether they are in an embryo or a stem cell, and to force 
them to make neurons in a controlled way. “We want to 
control their gene expression so that they make neurons, 
which would be useful for regenerative medicine,” says 
Moody. “This could be used to replace neurons in damaged 
neural tissue, as occurs in stroke — to grow replacements 
and then transplant them. It’s a long way off, but that’s the 
ultimate goal.”
Throughout her research, Moody continues to teach — in 
school, in her lab, and outside the university. Not long ago, 
she was giving a talk at an elementary school not far from the 
Rockville, Md., home she shares with her husband, Steven 
L. Klein, an NSF program director. Moody was wearing 
sneakers with low-cut socks, and suddenly one of her young 
listeners burst out: “Oh. My. God. She has a frog on her leg!”
Moody raised her pant leg above her right ankle, so 
everyone could see. Sure enough, it was a blue-ink tattoo of 
Xenopus, the product of a mother–daughter bonding experi-
ence with daughter Rachel at a Gaithersburg tattoo parlor.
Some folks wear their heart on their sleeve, metaphori-
cally. Sally Moody carries visible testimony of her devotion to 
research with every step she takes.  
Moody is looking for a method to control the gene expression 
of embryonic cells to encourage them to make neurons that 
could be used to replace damaged brain tissue.
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hen Elizabeth Ruckert graduated from Ithaca 
College with her Doctor of Physical Therapy 
(DPT) degree in 2006, she immediately accepted 
a job at a rehabilitation hospital in New Jersey, 
where she joined the traumatic brain injury rehab team. 
After just six months at the hospital, she began to question 
her decision. “I was feeling like there was so much I didn’t 
know, and I was realizing how hard it was to have structured, 
dedicated mentorship in this fast-paced health care environ-
ment,” she says. That’s when she began investigating physical 
therapy residency programs.
There were only two neurologic residency programs in 
the country at the time, and Ruckert chose to apply to the 
one at the University of Southern California (USC). She was 
accepted and spent the next year at Rancho Los Amigos 
National Rehabilitation Center, USC’s partner facility, where 
her foundational knowledge of neurologic practice and her 
clinical skills were further developed and refined through 
expert mentorship. The residency program also involved 
teaching in USC’s DPT program and conducting research 
in the school’s Neuroplasticity and Imaging Laboratory. 
“Each component of the residency program helped me attain 
a greater understanding of what comprises expert physical 
therapy practice. These experiences set the foundation for my 
path toward a future career in academia,” Ruckert says.
Ruckert, DPT, PT, NCS, GCS, now assistant professor 
in the Physical Therapy (PT) Program at GW’s School of 
Medicine and Health Sciences (SMHS), still cherishes her resi-
dency experience. So much so, in fact, that she is working with 
leadership in the Physical Therapy Department to develop a 
neurologic residency program here at SMHS in collaboration 
with the MedStar National Rehabilitation Network.
In accordance with the American Physical Therapy 
Association’s (APTA’s) strict credentialing requirements, 
a one-year pilot of the residency program will commence 
in August 2013. “Our mission is to develop neurologic 
specialist practitioners who demonstrate advanced clinical 
reasoning, assessment, and intervention skills for individuals 
with neurologic disorders across practice settings,” Ruckert 
says. The program will offer “very focused experiences and 
mentorship in neurologic physical therapy practice,” much 
like the experience offered in SMHS’s orthopedic residency 
program, which has existed in partnership with Johns 
Hopkins University since 2012.
Joyce Maring, Ed.D., DPT program director and 
associate professor at SMHS, notes that the field of physical 
therapy, like health care 
in general, is becoming 
more complex. “In order 
to provide the best-quality 
services, you really need 
practitioners and leaders 
who have advanced 
qualifications to be able 
to address the needs of 
a particular population,” 
Maring says.
Neurologic physical 
therapy focuses on the 
evaluation and treatment of individuals who have move-
ment problems as a result of disease or injury of the nervous 
system. “We’re movement dysfunction specialists,” Ruckert 
says. “The goal is to maximize someone’s return to function, 
to life roles.”
The challenging curriculum requires residents to 
immerse themselves in different components of neurologic 
specialty practice. The program has four primary focus areas: 
clinical practice, teaching, research, and didactic education. 
The residents — ideally there will be two during the pilot 
year — will be responsible for treating patients for 20 hours 
per week. The first four months will be spent on acute care, 
the second four months on acute rehabilitation, and the final 
four months on outpatient rehabilitation. 
They will also have a clinician mentorship, which 
Ruckert calls the hallmark of the residency program. “It’s 
focused time with a neurologic rehab specialist,” she says. “It 
gives the resident the opportunity to ask any questions they 
might have and engage in higher-level discussion related to 
clinical decision making, problem solving, and reflection.”
In addition to getting exposure to the entire health 
care continuum, the residents in the program will also have 
teaching opportunities within SMHS’s DPT program. 
Ruckert stresses the importance of including a teaching 
component in the model because “teaching requires synthesis 
of information at a much higher level. That’s very important 
to the development of a specialist’s understanding.” 
Ruckert has a palpable enthusiasm for expanding 
postgraduate education opportunities for new PT. “These 
programs are so important to the development of our new 
clinicians,” she says. “I’m impassioned about finding ways to 
let other people have the same opportunities that I feel so 
privileged to have had.”  
Physical Therapy on the Brain
gW’s Health sciences programs prepare to launch pt neurologic 
residency program
by KRISTIN HubING
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At GW, bridges between the clinic and the bench 
may revolutionize epilepsy care
Where seizures freeze
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hen Carrie Morgan1 turned 10 
years old, she learned she had a 
seizure disorder. For the next 28 
years, she would try to calm the 
intense and sudden attacks with 
every anticonvulsant in the book. 
Nothing worked; the seizures 
grew more frequent. By 2000, she was suffering as many as 10 
seizures per day. “My life was so restricted,” Morgan recalls. 
“I went from neurologist to neurologist, and they would just 
give up on me.” Then, Morgan met Samuel Potolicchio, M.D., 
the director of the Neurophysiology Center at the George 
Washington University Hospital (GW Hospital). He told her 
that by surgically removing a portion of her temporal lobe, the 
region of the brain where the seizures originated, he might be 
able to put an end to her attacks. 
Taking out a piece of the damaged brain is a scary propo-
sition, but not as scary as a life with uncontrolled seizures. 
Before committing to the surgery, however, the team needed 
to determine which side of Morgan’s brain dominated her 
verbal memory recall. Potolicchio and Anthony Caputy, M.D., 
professor and chair of the Department of Neurosurgery, had 
to confirm which sides of the brain had good or poor memory 
recall. More importantly, however, they needed to confirm 
that the side opposite of where the seizures were focused 
had good recall. To do that they performed the WADA test, 
named after Canadian neurologist Juhn Atsushi Wada, to 
determine the language and memory dominance between the 
hemispheres of the brain. 
The team anesthetized the right side of Morgan’s brain, 
and they asked her what Dr. Potolicchio held in his hand. 
“A pen,” she correctly answered. When he anesthetized 
the left side, Morgan recalls, “I couldn’t say what he was 
holding. I understood, but I just couldn’t say it.” Immediately, 
Potolicchio told her she an excellent candidate for the 
procedure, and that her WADA test results confirmed that 
she was quite safe in terms of her memory. Shortly after her 
38th birthday in 2001, Caputy performed surgery. She has not 
experienced a seizure since then, moreover she no longer takes 
medications to control her seizures, allowing her to fulfill her 
dream of graduating from college and becoming a medical 
technician. “I now have a new lease on life,” she says.
One-third of people with epilepsy cannot control their 
seizures with ordinary anti-epileptic drugs. Like Morgan in 
her teenage and young adult years, people with untreatable 
epilepsy are often barred from normal activities like swim-
ming or driving because they frequently lose control of their 
bodies. Unlike her, a subset of these patients are not able to 
be treated through surgery. Neurologists and neuroscientists 
at George Washington University (GW) find this outcome 
terribly troubling. The Epilepsy Center at GW Hospital has 
long helped those patients, and now it aims to do even better 
by translating cutting-edge science into patient care. For 
example, GW recently installed state-of-the-art equipment 
to monitor brain activity, which will help doctors pinpoint 
the origin of seizures so that they can tailor treatment to the 
individual. What’s more, collaborations between clinicians 
and researchers focused on the brain across the GW campus 
promise to usher in a wave of new and personalized seizure 
treatments in the years to come. 
“My vision for the center is to be at the forefront of 
utilizing the most advanced technology for the care of indi-
viduals with epilepsy, to be at the forefront of research, and to 
be a leader in epilepsy education,” says Mohamad Koubeissi, 
M.D., a neurologist directing the center. “Luckily,” he adds, 
“these objectives are interwoven.” Indeed, translational 
research requires an ever-flowing partnership between the 
scientists at the bedside and the bench.
A PLAnned ATTAck
Koubeissi’s interdisciplinary attack resonates among his 
colleagues at GW, as does his sense of urgency. “Only frequent 
dialogue between clinicians and basic scientists can make 
inroads into the big problems that have prevented cures for 
epilepsy thus far,” says Anthony LaMantia, Ph.D., director of 
the GW Institute for Neuroscience (GWIN). 
Methods to intervene with epilepsy have stalled in part 
because the brain is such a complicated organ to observe and 
manipulate. However, new technology that can image and 
monitor brain activities, and improved tools for analyzing 
the genes that reveal a risk of epilepsy and drug toxicity, may 
foster the next wave of advances. To this end, the center’s 
new system for monitoring the electrical activity in patients’ 
brains does not require patients to remain in their beds with 
wires connecting sensors on their scalps to computers at their 
bedsides. Now, the sensors wirelessly communicate with a 
hospital computer, meaning patients may be monitored more 
comfortably for longer periods. With this additional electro-
encephalogram (EEG) data, neurologists can more accurately 
predict where seizures arise in a person’s brain, and whether 
that person may be amenable to surgery or another investiga-
tional option. 
People who are not safe candidates for surgery may soon 
seek solace at GW too. GW has been exploring memory 
loss for several years with other researchers on campus, 
including GW’s Department of Psychology in the Columbian 
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College of Arts and Sciences. Koubeissi is investigating 
a couple of procedures that may avoid memory loss. One 
involves short-circuiting the seizure-generating section of the 
brain by snipping connections between it and neighboring 
regions. The second procedure is to electrically stimulate 
the malfunctioning area in order to get its signaling back on 
track. Through clinical trials to test these procedures at the 
GW Epilepsy Center, patients with no viable options would 
be offered the opportunity to try something new. “Following 
the textbook, we currently tell these patients, I’m sorry, 
there’s nothing we can do; you will live with your seizures,” 
Koubeissi says. “In the future, we want to explain that we’ve 
done everything in the textbook, but there may be procedures 
we can offer that might help you without interfering with your 
memory.”
BAck In THe LAB
For many years GW and the Department of Neurosurgery has 
been a leader in the exploration into procedures using electri-
cal pulses, called deep brain stimulation. Continuing in that 
tradition, Koubeissi is investigating his own techniques into 
the procedure. In preparation for the trials he hopes to soon 
lead, Koubeissi is refining new methods of delivering electrical 
pulses using rats with epilepsy. He studies them in his labora-
tory in GW’s Institute for Neuroscience. “People talk about 
moving findings from the lab to the clinic, but it works both 
ways,” Koubeissi says. “It’s clinic to lab, lab to clinic. It’s this 
type of dynamic relationship that we want to foster at GW.” 
Judy Liu, M.D., Ph.D., assistant professor of pediatrics at 
the GW-affiliated Children’s National Medical Center (Chil-
dren’s National) and member of its Center for Neuroscience 
Research, operates in a similar manner. She focuses on the 
neurological disorder lissencephaly, in which a person’s brain 
cells do not migrate to the correct spot during early child-
hood. By age 10, children begin suffering from seizures and 
mental disabilities. Various mutated genes underlie the disor-
der, and Liu learns how these genes affect neuronal migration 
by altering them in mice, and analyzing the downstream 
changes in proteins that occur. “If we can figure out which 
proteins become dysregulated in the mice,” Liu says, “we can 
think about trying to alter proteins in patients in order to 
counteract seizures.”
Liu’s laboratory work also focuses on samples from 
patients, which ensures that what she discovers in mice is 
applicable to humans. Liu collaborates with neurologists at 
Children’s National. Weekly, she and the neurologists gather 
to discuss difficult cases, including any children who might 
go to surgery to ameliorate their epilepsy. When surgeries are 
performed, Liu, or a member of her laboratory, heads to the 
operating room to learn more about the patient and to observe 
exactly which part of the brain the neurosurgeons remove. 
They then cart the extracted tissue back to Liu’s laboratory 
for analysis. “We usually find that the tissue is more prone to 
[electrical] excitation, and we examine which genes are on and 
off compared to normal brain tissue,” Liu explains. “Next, we 
recapitulate those changes in mice so that we can understand 
the problems those genes cause.” Soon, Liu hopes to collabo-
rate with neurologists at the Epilepsy Center to examine adult 
brain tissue. 
Neurologists at the Epilepsy Center already converse with 
GW’s neuroscientists on a regular basis. Recently, Koubeissi 
helped Matthew Colonnese, Ph.D., an assistant professor at 
the GWIN, understand patterns he saw in an EEG from a 
rat brain. Colonnese studies the erroneous brain develop-
ment that occurs in the genetic disorder Fragile X syndrome. 
In humans, the disorder is a common cause of epilepsy and 
mental disability, but parents often do not detect that their 
child has the disorder until they are at least 2 years old. If 
scientists could pinpoint when neurons begin to misfire during 
a baby’s development, Colonnese suspects they might develop 
a way to intervene before the problem becomes irreversible. To 
learn when the problems begin, Colonnese experiments with 
rats, engineered by an outside firm to bear a similar genetic 
mutation, observing them as they develop Fragile X syndrome. 
He has already had promising results: Before the rats showed 
any behavioral signs of having Fragile X syndrome, Colonnese 
noticed that some of their EEGs looked different from the 
EEGs of normal rats. “I saw crazy activity patterns, and so I 
asked Mohamad [Koubeissi] to look at the graph,” says Colon-
nese. “He pointed to a spike followed by a wave of activity and 
described the type of seizure it was.” Although the baby rats’ 
muscles were not seizing up, the rats were enduring the first 
neurological components of seizures. 
BrIdGe BuILders
Translating findings from the laboratory to the clinic begins 
with interdisciplinary collaborations like these. To facilitate 
 Partners without boarders. Matthew Colonnese, Ph.D.; Judy Liu, 
M.D., Ph.D.; and Mohamad Koubeissi, M.D., form an information 
exchange that moves data from clinic to lab as well as lab to clinic.
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Core strength
Collaborative research is engineered into the Institute 
for Neuroscience. At the institute’s Biomarker 
Discovery and Analysis Core Facility, researchers 
from the Neurology Department as well as myriad 
other centers across the GW campus gather in search 
of molecular biology services, tools, and expertise. 
There, researchers can have the DNA within their 
samples analyzed with high-throughput polymerase 
chain reaction platforms, microarrays, and in situ 
hybridization. Alternatively, they may visit the core 
facilities to conduct experiments that involve fluores-
cence microscopy; transgenic animals, plants, and 
bacteria; or embryonic stem cells from mice. This 
consolidation of resources saves money for individual 
laboratories on campus because they do not need to 
purchase their own equipment from scratch. In addi-
tion, it allows investigators to pursue questions outside 
their laboratory’s—and often their department’s—reach. 
Finally, it offers investigators from disparate realms 
a place to collaborate. “You can’t force people to do 
things together, but you can provide opportunities 
that enable people with a variety of interests to coop-
erate,” says Anthony LaMantia, Ph.D., director of the 
GW Institute for Neuroscience. 
Much of the work conducted at the core facility 
applies directly to biomedical issues. For example, 
Thomas Maynard, Ph.D., director of the facility, uses 
tools at the core to analyze changes in gene expres-
sion that result in seizures, learning disabilities, and 
other symptoms of DiGeorge syndrome. Scientists 
know that the syndrome is caused by a DNA dele-
tion in a part of the human genome called 22q11.2; 
however, they do not yet understand how this defect 
disrupts protein networks to cause neurological 
problems. Maynard’s findings unexpectedly aided 
Irene Zohn, Ph.D, of Children’s National Medical 
Center, when she visited the core facility to learn 
which genes and proteins caused neurological 
defects in malformed mice embryos. Maynard and 
Zohn realized that a protein from Maynard’s experi-
ment on DiGeorge syndrome, the nutrient retinoic 
acid (or vitamin A), also went awry in Zohn’s embryos. 
those interactions, clinical and neuroscience departments host 
seminars, and the Epilepsy Center hosts a monthly series of 
lectures by epilepsy experts from around the world. In addi-
tion, GW researchers can conduct their brain-related experi-
ments in a well-stocked core facility located at the GWIN 
(see sidebar). Henry Kaminski, M.D., the chair of GW’s 
Department of Neurology, trusts that basic findings will move 
to the clinic at GW because the heads of each component 
actively push for translation. “I meet with scientists and clini-
cians in other departments spontaneously because I want to 
promote this type of interaction,” Kaminski says. 
Kaminski suggested expanding the Epilepsy Center in 
2011 for several reasons. First, he knew that top neurologists 
and neurosurgeons at the center recognized the importance of 
research in finding new treatments, and therefore, that they 
might interact with neuroscientists like LaMantia elsewhere 
on the GW campus. Second, Kaminski and GW Hospital’s 
clinical partners appreciated an unmet need for the Epilepsy 
Center in the greater Washington, D.C., area. “GW is among 
the few places that patients with difficult cases can go,” says 
Kaminski. 
“We have the opportunity to establish a continuity 
between pediatric neurology at Children’s National and adult 
neurology at GW,” says Vittorio Gallo, Ph.D., professor of 
pediatrics and of pharmacology and physiology at GW, and 
the Wolf-Pack Chair in Neuroscience and director of the 
Center for Neuroscience Research at Children’s National. 
The collaborative work between Colonnese, Koubeissi, 
and Liu, adds Gallo, is a prime example of how investiga-
tors can find colleagues whose research interests interface 
with their own. That exchange, adds Gallo, goes both ways. 
Normally, he says, research flows from basic science questions 
to translational research and ultimately ends up as clinical 
applications. “What we are able to do in this setting is reverse 
that pipeline. Physicians are able to find partnerships to study 
mechanisms that are at the basis of therapeutic applications 
by working together with investigators who are using animal 
models of disease.”
One of the greatest medical challenges of the 21st century 
is finding cures for brain disorders. Neurological problems 
have been nearly impossible to solve because the brain is diffi-
cult to study and difficult to treat. Despite these hurdles, the 
army of clinicians and researchers across GW are well posi-
tioned to make a serious dent in the toll that seizures take on 
patients. On their side are modern medical and scientific tools, 
the push to interact across sectors, and raw drive. “As a doctor, 
I got tired of telling patients and their parents, we don’t know 
why these seizures happen and we can’t tailor our therapy to 
you or to your child,” Liu says. “That’s why a lot of us are back 
in the lab, so that five to 10 years down the road we can target 
therapy to specific patients.”  
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t 9:40 a.m. on Dec. 14, 2012, a troubled 
20-year-old walked into Sandy Hook 
Elementary School and gunned down 20 
children and six adults. The tragic event 
followed a pattern of 16 similar events 
that year, crisscrossing the nation and 
leaving 88 men, women, and children 
dead. The horrible nature of the crime 
reignited a long-simmering debate over access to guns, 
weapon types, and the capacity and availability of ammuni-
tion magazines. 
Just a few days removed from the events, however, Kurt 
Newman, M.D., president and CEO of Children’s National 
Medical Center (Children’s National), and professor of 
surgery at GW’s School of Medicine and Health Sciences 
(SMHS), raised his voice to offer a new focus to the discus-
sion — pediatric mental health.
The tragedy in Newtown, Ct., offered the opportunity 
to draw attention to an issue Newman and other health care 
professionals believe is long overdue. Immediately following 
the incident, issues involving guns and gun violence were 
on everyone’s lips. “While that’s probably appropriate, it’s 
almost entirely an after-the-fact approach,” says Newman. 
“There is another big dimension to this, and that is the 
mental health of children.
“To me, it doesn’t feel like our country is focused on 
kids’ mental health — pediatric mental health is not being 
addressed in the same way we address other diseases,” 
explains Newman. 
Soon after, Newman penned an editorial, titled “The 
Treatment of Mental Conditions Must Start Early,” which 
was published in the Dec. 27 edition of The Washington Post. 
In it, he outlined the scope of the problem and offered several 
steps for addressing gaps in pediatric mental health care and 
thereby securing a better future for the nation’s children.
First among Newman’s recommendations was to take 
a moment to simply accept the magnitude of the problem. 
Shooting incidents like the ones that occurred at Sandy 
A Call
to Arms
national tragedies 
prompt health care 
leaders to move 
mental health to 
the forefront
by THOmAS KOHOuT
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Hook, Virginia Tech, and Columbine High School paint 
a picture of pediatric mental health in the extreme. The 
real tragedy, he argues, is in the scope of the issue, not the 
severity of a few iconic cases. According to the National 
Institute of Mental Health, one in five children in the United 
States suffers from a mental health-related problem; of the 15 
million children affected by such conditions, only 20 percent 
ever receive treatment.
Such an outsized figure might seem farfetched, explains 
Paramjit T. Joshi, M.D., professor of psychiatry and behav-
ioral sciences at SMHS, director of psychiatry at Children’s 
National, and president-elect of the American Academy of 
Child & Adolescent Psychiatry, but that is because public 
attention is often drawn to more intense mental health 
disorders such as schizophrenia. “Among the 20 percent of 
children with a mental health diagnosis, roughly 5 percent 
have a serious mental health condition,” says Joshi. The 
majority of cases “experience an array of difficulties that are 
very treatable, such as depression, anxiety, eating disorders, 
and ADHD.”
The key to addressing the mental health needs of 
children and adolescents is early screening. As with any 
other illness, making an early diagnosis often leads to better 
outcomes. Therefore, it is very important to identify children 
who either are at risk or may already be exhibiting some 
symptoms of these disorders. Although externalizing disor-
ders such as ADHD and oppositional defiant disorder come 
to adult attention readily, says Joshi, internalizing disorders 
such as anxiety or depression do not. “You don’t see it, but 
children feel it.” Most children with internalizing disorders 
might never be diagnosed, especially if they have no overt 
behavioral difficulties. If they are diagnosed, often there is a 
long delay between symptoms and identification.
The average length of time between when a child begins 
experiencing symptoms and diagnosis and treatment is 
between eight and 10 years, according to Newman. By that 
time, the child is well on the way to becoming an adult, when 
behaviors become more entrenched. “If we could move that 
timeline forward,” he says, “we could get them into treatment 
sooner and we could have a major impact on their long-term 
quality of life — and the safety and health of our larger society.” 
Enlisting aid from the basic sciences is another area 
where Newman sees hope for solutions. Discoveries in 
genetic research have already begun to transform the land-
scape for cancer and metabolic disease treatment, and both 
Newman and Joshi see discoveries in genetics and predictive 
or anticipatory medicine as offering the potential for very 
individualized diagnosis and treatment in the future. 
As is the case in every discussion about health care, 
access to care is the linchpin that holds together any plans 
for improvement. In many ways, the United States is ahead of 
the rest of the world in terms of pediatric mental health care. 
Among U.S. allied health professionals, there are nearly 8,700 
child and adolescent psychologists, as opposed to roughly 
400 in Canada. But, in a nation of almost 314 million people, 
with children under age 18 making up about 24 percent of the 
population, there are still huge gaps in coverage.
Even in a densely populated region like Washington, 
D.C., Children’s National is the only pediatric emergency 
mental health care facility in the area. Each month, more 
than 200 children pass through its doors seeking emer-
gency psychiatric care. “In terms of inpatient facilities, 
Washington, D.C., has two facilities,” says Joshi. Children’s 
National, one of those two inpatient facilities in the city, has 
just 26 beds available; 12 beds for children under the age of 13, 
and 14 beds for patients between 14 and 18 years of age.
Elsewhere in the country, she says, are states with no 
psychiatric inpatient facilities for children and adolescents. In 
those cases, patients are admitted to facilities in nearby states. 
“You can just imagine how disjointed that makes the care,” 
Joshi says. “The family is unable to participate in a meaningful 
way because the child is so far removed.” And that, says Joshi, 
can have serious ramifications for treatment outcomes.
Newman adds that it’s possible the health care system 
needs to consider new models of care, such as co-locating a 
mental health professional with pediatricians, or training 
teachers or school nurses as virtual mental health care 
first responders.
“One of the issues that becomes apparent is that we 
aren’t training enough people,” says Newman. “As a nation, 
we aren’t educating enough health professionals and psychol-
ogists to deal with these great numbers.” 
Partnerships like those between SMHS and Children’s 
National have the resources, expertise, and inclination to 
take a leading role in this national initiative. “That’s an 
important role I think George Washington University can 
fill. We need the research, we need the education, and we 
need advocacy. In order to be effective, all of these assets and 
the clinical care given to kids at Children’s National need to 
move in parallel,” says Newman.  
According to the National Institute of mental Health, one in 
five children in the united States suffers from a mental health-
related problem; and of the 15 million children affected by 
such conditions, just 20 percent ever receive treatment.
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off the Hook
gW researchers Close in on Hookworm Vaccine
it has been decades 
since the last case 
of hookworm was 
reported in the United 
states, but the intestinal 
parasite still infects 
more than 500 million 
people throughout the 
developing world. 
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n the surface, the groundbreaking 
research being performed by Jeff 
Bethony, Ph.D., and David Diemert, 
M.D., which involves bringing hookworm 
back to the United States, may seem 
counterproductive. But they’re well on 
their way to developing a vaccine that could eradicate this 
persistent tropical disease worldwide.
After more than 15 years of research, Bethony and 
Diemert, both associate professors of microbiology, immu-
nology, and tropical medicine at GW’s School of Medicine 
and Health Sciences (SMHS), are currently conducting 
first-in-human studies of two hookworm vaccine candidates, 
Na-GST-1 and Na-APR-1. A vaccine for hookworm — a 
disease that causes anemia and can lead to problems with 
physical and cognitive development in children — could revo-
lutionize the way it is controlled.
The current strategy is based on mass drug administra-
tion, an approach in which anti-worm drugs are given to all 
children in endemic areas once a year. Diemert says that in 
addition to being logistically challenging, the strategy is inef-
fective. “Kids get re-infected after they are treated,” he says. 
“And there is evidence that the drugs become less effective 
over time.”
For these reasons, Bethony and Diemert are focused on 
developing a vaccine that would prevent serious hookworm 
infections from occurring in the first place. Their unique 
approach is to attenuate the nutritional process of the hook-
worm — effectively starving it out. “It’s a very new, novel way 
of creating an anti-parasite vaccine,” Bethony says.
With support from the Sabin Vaccine Institute Product 
Development Partnership (formerly known as the Human 
Hookworm Vaccine Initiative), Bethony and Diemert are 
developing the first challenge model that has ever been 
done for hookworm. “This will allow for early assessment 
of proof of concept,” Diemert says of the Phase 1 clinical 
trial, which is proposed to take place at the GW Medical 
Faculty Associates.
After undertaking a safety feasibility study with over-
sight from the U.S. Food and Drug Administration and GW’s 
Institutional Review Board, the researchers will inoculate 
healthy volunteers with their candidate vaccine. They will 
then give the volunteers an effective dose of hookworm 
larvae, which is transmitted through skin penetration, to test 
for the protective effect of the vaccine.
“This will help us enormously as far as speeding up the 
timelines for allowing decisions to be made as to which vaccine 
candidates are the most promising,” Diemert says. There are 
currently two vaccines in consideration, which they plan to 
combine into a single product. Bethony adds that once this 
model is established, “if any other hookworm vaccines come 
along, this will be the basis on which they’ll test it.”
Although the U.S. “challenge” study is still more than a 
year off, Bethony and Diemert have already begun a Phase 
1 clinical trial of Na-GST-1 in the state of Minas Gerais in 
southeastern Brazil, where they’ve been working in conjunc-
tion with the Ministry of Health since 2003.
There, they’ve built a lab and a clinic in partnership with 
the Oswaldo Cruz Foundation (FIOCRUZ), which houses 
a staff of more than 30 people, including clinicians, nurses, 
regulatory affairs specialists, lab technicians, and researchers. 
The Brazilian government, very supportive of the initiative, 
recently gave FIOCRUZ a $1 million grant to conduct addi-
tional clinical trials of the hookworm vaccine. 
Back in the United States, Bethony and Diemert are 
excited to be making plans for the clinical trials to begin 
at GW. “It’s a big step for us to do vaccine studies here,” 
Bethony says. “It really integrates us. We use the whole 
GW infrastructure and get to involve more faculty.” John 
Hawdon, Ph.D., associate professor of microbiology, immu-
nology, and tropical medicine at SMHS, will be managing 
the sampling of the pathogen when it arrives here in 
Washington, D.C. 
Bethony and Diemert are especially grateful for 
the funding they’ve received for another Phase 1 trial of 
Na-GST-1 from GW, through the Clinical and Translational 
Science Award (CTSA) program. This study is currently 
underway at Children’s National Medical Center and has 
enrolled more than 20 healthy adult volunteers. “The pilot 
funding from the CTSA has been critical,” Bethony says. 
“It allowed us to establish a clinical structure, learn how to 
recruit in D.C., and train our lab in how to receive samples 
and work on human biomaterial.”
“It’s important in terms of vaccine development, too,” 
Diemert adds. “We’re testing different formulations and 
different ingredients to see if we can fine-tune immune 
response. It’s contributing to us being able to make a 
better vaccine.”  
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fOCAL 
Point
GW’s Mary Ann 
Stepp, Ph.D., 
probes the healing 
potential of stem 
cells to save the 
sight of millions
I f the eyes are the windows to the soul, then Mary Ann Stepp, Ph.D., has the most soulful research job in medi-cine. Her focus is the eye, and specifically the cornea, the clear outer layer, in studying the cellular mecha-nisms related to wound healing. Mysteries of sight are 
revealed, and the potential for healing corneal damage finally 
realized. Windows indeed!
And thanks to a dearth of doctoral programs, Stepp, who 
was an aspiring nutritionist, changed direction to become 
one of the leading researchers in her field.
As a member of the GW Stem and Progenitor Cell 
Research Group, Stepp has been working with adult stem 
cells found in the cornea to probe their potential for healing 
damage from splashed chemicals, thermal burns, and other 
injuries. Corneal erosions can develop after ocular trauma, 
causing chronic inflammation and interfering with the 
quality of life for millions of Americans. Corneal surface 
injuries are painful and expose the eye to infectious microor-
ganisms that can impair vision.
A professor of anatomy and regenerative biology and 
of ophthalmology at GW, Stepp received her first R01 
grant for corneal research from the National Institutes of 
Health in 1990 and has been continuously funded by NIH 
since then — a winning streak of dynastic proportions. 
Her secret? “Write a good proposal, and if your interests 
match theirs, you’ll be successful,” she explains. But then 
the slight, self-effacing scientist accumulates honors at a 
daunting pace, including a 2010 Gold Fellow award from 
the Association for Research in Vision and Ophthalmology 
(ARVO). Stepp is also a tireless advocate for female Ph.D.s 
at GW and for her lab partners.
Stepp examines the roles played by cell matrix adhesion 
molecules, called “integrins,” during corneal and skin wound 
healing, and in maintaining the stem cell population that 
gives rise to the cells that make up the corneal surface. She 
wants to understand how the cells that form the epithelial 
niche of the cornea are maintained and what happens to 
those cells and their niche when the tissue they serve is 
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injured. “To be able to prevent stem cell loss and recurrent 
corneal erosions,” she says, “we need to understand how 
they happen.”
Corneal abrasions are the most common reason a person 
seeks out an ophthalmologist and are a regular cause of visits 
to the ER, usually triggered by an errant fingernail. Infants 
waving little hands often cause injury to their parents. Soldiers 
experience eye trauma from shrapnel or debris. “Usually the 
eye responds normally and there are no complications,” says 
Stepp. “But I’m exploring how wound healing occurs so we can 
help those who do have complications.” Such complications 
may include lasting pain, watering of the eyes, the sensation 
that something is in the eye, or scratchiness.
“When you sleep at night, your cornea swells because it’s 
generating carbon dioxide, which builds up,” she explains. 
“So your first blink of the morning is like a shirt that’s too 
tight — the outer layer of cells can come off. You get focal 
erosions that have to heal and can be painful. Every time that 
happens, you weaken the adhesions of the epithelial to the 
basement membrane. It’s like a spiral.”
Dimitri Azar, M.D., M.B.A., dean of the University of 
Illinois College of Medicine and a cornea expert, calls Stepp 
“one of the most highly talented researchers in the field of 
corneal wound healing. Her studies on the role of epithelial 
cells during a corneal wound, either in a situation of recur-
rent erosion syndrome or during wound healing, have had a 
significant impact on our understanding of the mechanisms 
of wound healing and our therapeutic interventions.”
Stepp’s upbringing shaped the course of her life. Her 
father had a long career working for the Public Health 
Service and her mother taught school. “I got an interest in 
the allied health fields from my dad, and my mom gave me a 
sense that you had to have a career and marry someone who’s 
supportive of that career,” recalls Stepp. 
Yet it was the stomach, not the eye, upon which she first 
set her sights.
“One of the appropriate jobs for women when I was 
growing up was a nutritionist or dietitian. There weren’t 
very many programs, but I was able to get a scholarship to 
go to Simmons College in Boston as a work-study student 
and major in nutrition,” she says. But there were few Ph.D. 
programs in nutrition, so Stepp was advised to pursue a 
doctorate in biochemistry to advance in her chosen field. 
The pivotal point in her career came during her doctoral 
studies at Boston University, where she was working in a 
lab studying the extracellular matrix, the part of animal 
and human tissue that usually provides structural support 
to the animal cells and is the defining feature of connective 
tissue in animals. “That’s when I gave up on nutrition,” she 
recalls. “I got interested in the extracellular matrix and the 
biochemistry of that.” 
That led to postdoctoral work at MIT in a lab directed 
by Richard Hynes, Ph.D., well known for his work with 
fibronectin, one of the extracellular matrix proteins. “It was 
very exciting to study a new family of proteins called integ-
rins. They integrate the intracellular part of the cell with the 
extracellular matrix,” she explains. While attending a New 
Hampshire conference related to her research, Stepp met 
Ilene K. Gipson, Ph.D., of Boston’s Schepens Eye Research 
Institute. Gipson recruited Stepp. “It seemed to me a niche 
field was a good place to go because you could be identified as 
an expert and have an impact,” Stepp says. “What attracted 
me to the corneal studies was the simplicity and beauty of the 
models that existed to study cell migration.”
Within eight months she had written a grant and 
received funding through the National Eye Institute at 
NIH. She was 32 years old. Her first office at Schepens was 
a coat closet, but her salary doubled and she was able to 
pay her child care costs. In 1992, when her husband, Jerry 
Bell, got an offer to work at the American Association for 
the Advancement of Science in Washington, D.C., Stepp 
joined the GW School of Medicine and Health Sciences as a 
research assistant professor.
A new grant will allow her to continue research on treat-
ment of perceived stem cell deficiencies in the cornea. “I’m 
attempting to overthrow a paradigm,” she says with a quick 
grin. Don’t bet on the paradigm.  
>> ON THE WEB
Scan this QR code with any mobile device for 
related content — available online below the story.
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Genetic Lesion Blocks Neuron 
Critical for Cortical Development
A little-known genetic irregularity has been identified as the 
prime suspect in a developmental genetic defect leading to 
disorders such as autism. Anthony-Samuel LaMantia, Ph.D., 
professor of pharmacology and physiology at GW’s School 
of Medicine and Health Sciences (SMHS) and director of 
the GW Institute for Neuroscience, along with postdoctoral 
fellow Daniel Meechan, Ph.D., and Thomas Maynard, Ph.D., 
associate research professor of pharmacology and physiology 
at SMHS, authored the study, titled “Cxcr4 Regulation of 
Interneuron Migration Is Disrupted in 22q11.2 Deletion 
Syndrome,” in the journal Proceedings of the National 
Academy of Sciences (PNAS).
For nearly a decade, LaMantia and his colleagues have 
been investigating how illnesses such as autism, attention 
deficit hyperactivity disorder (ADHD), and schizophrenia 
arise during early brain development. This latest research 
focuses specifically on the effects on cortical circuit develop-
ment of having lower levels of the gene 22q11.2.
According to LaMantia and his team, research shows for 
the first time that genetic lesions known to be associated with 
autism and other behavioral diseases disrupt the mechanisms 
that ensure normal development of a key type of cortical 
neuron: the interneuron. Previous investigations found that 
among people who have these diseases, too little of another 
type of cortical neuron, the projection neuron, is generated 
during cortical circuit development. Interneurons, according 
to LaMantia, are formed in the correct numbers outside the 
cortex, but are not able to move properly into the cortex where 
they are needed to control cortical circuit activity. 
“This gives us two pieces of the puzzle for this genetic 
developmental disorder,” says LaMantia. “These two pieces 
tell us that in very early development, those with 22q11.2 
deletion syndrome do not make enough cells in one case, 
and do not put the other cells in the right place. This occurs 
not because of some degenerative change, but because the 
mechanisms that make these cells and put them in the right 
place during the first step of development have gone awry 
due to mutation.”   
Keeping the Cardiology  
Community on the Beat
Cynthia Tracy, M.D., professor of medicine at GW’s School 
of Medicine and Health Sciences, and associate director of 
the GW Medical Faculty Associates’ Division of Cardiology, 
was recognized by the American College of Cardiology 
Foundation (ACCF) and the American Heart Association 
(AHA) for her efforts as writing group chair for the team 
that updated the ACCF/AHA clinical practice guidelines. 
The new guidelines will provide evidence-based guid-
ance to physicians and other health care providers practicing 
cardiovascular medicine. The standards will also help provide 
a foundation for other applications, such as performance 
measures, appropriate use criteria, and both quality improve-
ment and clinical decision support tools. 
Tracy was chosen for this initiative because of her exper-
tise and leadership at the national level and her service to the 
cardiology community at large.   
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Speaking Out in Support of  
Nutritional Standards for  
Pregnant Women
Pregnant women in the United States face possible serious 
side effects for both themselves and their unborn children 
due to low levels of iodine in their diets. In an article from 
the December 2012 edition of the Journal of the American 
Medical Association, Alex Stagnaro-Green, M.D., MHPE, 
professor of medicine and professor of obstetrics and gyne-
cology at GW’s School of Medicine and Health Sciences 
(SMHS), along with co-author Elizabeth Pearce, M.D., 
M.Sc., associate professor of medicine at Boston University 
School of Medicine (BUSM), supports guidelines issued by 
the American Thyroid Association, Endocrine Society, and 
Teratology Society calling for pregnant women to take daily 
iodine supplements.
“Iodine levels in the United States have been decreasing, 
which has the potential to negatively impact the mother 
and unborn child,” says Stagnaro-Green. “It’s time for all 
health care professionals to make sure that every pregnant 
and breast-feeding woman gets supplemental iodine during 
pregnancy and while she is breast-feeding.”
Iodine is not naturally made in the human body and 
must be consumed through foods rich in the element or 
through supplements. Iodine is required for the production 
of thyroid hormone, and adequate thyroid hormone levels 
are critical for normal fetal neurodevelopment. National and 
international health organizations currently recommend that 
pregnant women take at least 150 milligrams of potassium 
iodide daily.
“There is concern that even mild iodine deficiency in 
pregnant women could lead to children with lower IQs,” 
says Pearce. Iodine deficiency remains the leading cause of 
preventable mental retardation worldwide.   
Health Sciences Faculty Honored 
for Teaching Excellence
GW School of Medicine and Health Sciences faculty 
members Jennifer Halvaksz, M.A., assistant clinical professor 
of physical therapy and health care sciences, and Karen 
Schlumpf, M.P.H., lecturer in clinical research and leader-
ship, received the 2013 Bender Teaching Award for their 
demonstrated excellence in teaching and high academic 
standards for achievement. 
Halvaksz and Schlumpf join the ranks of other SMHS 
faculty members who have been awarded the Bender 
Teaching Award, including Gaetano Lotrecchiano, Ph.D., 
assistant professor of clinical research and leadership; Ozgur 
Ekmekci, Ed.D., M.B.A., assistant professor of clinical 
research and leadership; and Ellen Costello, Ph.D., associate 
professor of physical therapy and health care sciences. Each 
award includes a $1,000 prize to be used by the winners for 
developmental activities.  
Research Team Identifies  
Biomarkers for Acute Kidney Injury
Two biomarkers used in combination can improve risk assess-
ment of acute kidney injury (AKI), according to new research 
from an international multicenter study. AKI strikes up to 7 
percent of hospitalized patients and is associated with signifi-
cant morbidity and mortality. 
The results, published in the journal Critical Care, 
address one of the most costly and deadly conditions 
affecting critically ill hospitalized patients. The findings 
provide much-needed insight into the most compelling 
biomarkers of AKI. 
AKI is a complex and increasingly prevalent condition. 
Although it occurs quickly (over the course of hours to days), 
it commonly presents a challenge in risk assessment due to 
the inadequate tools currently available to physicians. Failure 
to recognize and manage AKI in the early stages can lead to 
devastating outcomes for patients and increased costs to the 
health care system.
Lakhmir Chawla, M.D., associate professor of anesthesi-
ology and critical care medicine at GW’s School of Medicine 
and Health Sciences, and John A. Kellum, M.D., professor of 
critical care medicine at the University of Pittsburgh, were part 
of a two-part study on AKI, along with Kianoush Kashani, 
M.D., assistant professor of medicine at the Mayo Clinic.
Researchers evaluated nearly 340 biomarkers to define the 
two best biomarkers with the highest correlation to risk of AKI. 
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Chawla and Kellum led researchers from 35 medical centers in 
validating the effectiveness of the two novel biomarkers in 740 
critically ill patients and comparing their performance with 
other biomarkers, including serum creatinine. 
The research teams confirmed that insulin-like growth 
factor–binding protein 7 (IGFBP7) and tissue inhibitor of 
metalloproteinases-2 (TIMP-2), both inducers of G1 cell cycle 
arrest, were key mechanisms implicated in AKI. “The results 
are striking not only in terms of identifying new robust 
markers that have improved performance characteristics 
when directly compared with existing methods for assessing 
risk of AKI, but also in terms of bolstering understanding of 
the mechanism of this disease,” says Chawla.   
GW Faculty Members Lead the 
Way for Women in Medicine
GW School of Medicine and Health Sciences faculty 
members Katherine Chretien, M.D., associate professor of 
medicine; Carolyn Clancy, M.D., associate clinical professor 
of medicine; and Laura Tosi, M.D., associate professor of 
orthopedic surgery, were among five distinguished women 
honored at the sixth annual American Medical Student 
Association (AMSA) Women Leaders in Medicine Awards.
According to Lexi Light, chair of AMSA’s Gender and 
Sexuality Action Committee, Chretien, Clancy, Tosi, and 
their fellow awardees “have committed themselves to educa-
tion, social justice, and civic engagement.”  
SMHS Alumna 
Named Chair of 
Dermatology
Alison Ehrlich, M.D. ’96, 
M.H.S., clinical professor 
of dermatology and director 
of dermatology clinical 
research, has been named 
the new chair of the 
Department of Dermatology 
at the GW School of 
Medicine and Health Sciences (SMHS).
“The GW School of Medicine and Health Sciences is 
proud to have Dr. Ehrlich as its new chair of dermatology,” 
says Jeffrey S. Akman, M.D. ’81, G.M.E. ’85, vice president 
for health affairs and dean of SMHS. “Her years of clinical 
experience, research, and leadership in the field of derma-
tology make her the right candidate to lead and expand this 
department. We are especially pleased to have one of our very 
own SMHS alumnae in this position.”
Ehrlich is an expert in the field of allergic contact derma-
titis and founder of the GW Medical Faculty Associates’ 
psoriasis clinic, which offers patients a wide variety of therapy 
options, including phototherapy, laser, biologics, and clinical 
trials. She has been listed among America’s Top Physicians by 
the Consumers Research Council of America and has been 
named a Washingtonian Magazine “Top Doctor.”     
Study Explores 
Methods to Bet-
ter Pair Patients 
with Treatments
A study led by Robert G. 
Hawley, Ph.D., professor and 
chair of the department of 
anatomy and regenerative 
biology at the GW School 
of Medicine and Health Sciences (SMHS), may help predict 
which patients with multiple myeloma will respond better 
to certain treatments. The study, titled “Identification of an 
ABCB1 (P-glycoprotein)-positive Carfilzomib-resistant 
Myeloma Subpopulation by the Pluripotent Stem Cell 
Fluorescent Dye CDy1,” was published in April 2013 in the 
American Journal of Hematology, 88(4), 265-272.
Multiple myeloma, the second most common blood 
cancer in the United States, is an incurable malignancy 
involving the white blood cells that normally produce 
antibodies. As the disease progresses, the cancerous cells 
accumulate in the bone marrow, causing painful bone lesions 
and preventing normal blood cell production. 
“Our hope is that the fluorescent assay we have devel-
oped will help physicians monitor the newest treatment 
option for multiple myeloma patients and determine how well 
it is working,” says Hawley.
Hawley and his team of researchers reported a test that 
could be used to detect the multiple myeloma cells that 
survive chemotherapy and are responsible for disease relapse 
(referred to as tumor-propagating cells). 
The researchers tested the hypothesis that the tumor-
propagating cells in multiple myeloma exhibit stem cell–like 
properties that confer resistance to the chemotherapeutic 
agents used to treat patients. The team’s long-term goal is to 
characterize these so-called “cancer stem cells” in order to 
develop new targeted therapies that will eradicate the cells 
and cure the disease.   
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The next phase of the project, which is supported by a 
pilot research grant awarded in 2012 by the Dr. Cyrus and 
Myrtle Katzen Cancer Research Center at GW, will be to 
translate the laboratory findings to the clinic. This work, 
which will be carried out in collaboration with Imad Tabbara, 
M.D., professor of medicine at SMHS, will involve screening 
multiple myeloma patients to determine whether the CDy1 
assay can help guide treatment decisions or predict which 
patients will respond better to carfilzomib.  
Art and History in Urology
Harry C. Miller Jr., M.D., professor and chair emeritus of 
the Department of Urology at GW’s School of Medicine 
and Health Sciences (SMHS), recently received the William 
P. Didusch Art and History Award from the American 
Urological Association (AUA), for his outstanding contribu-
tions to the written and photographic history of urology. The 
AUA awards program honors the contributions of physi-
cian researchers and educators to the field of medicine, the 
specialty of urology, and the association. Miller was a key 
member of the SMHS faculty for 23 years, beginning in 1973, 
until his retirement in 1995.
In retirement he remains active in medical organiza-
tions, serving on the boards of directors of the American 
Urological Association and the American Association of 
Clinical Urologists.  
The Next Phase of the  
Fantastic Voyage
In the 1960s, it was the stuff of science fiction: the prospect 
of journeying inside a patient to locate the source of illness 
and identify the most effective means of treatment. Then, 
about a decade ago, physicians began making that voyage 
through the body by means of tiny video cameras the size 
and shape of an oversized pill swallowed by the patient. 
Now, emergency departments are exploring the use of video 
capsule endoscopy to detect potentially life-threatening 
acute upper gastrointestinal bleeding, enabling patients with 
gastrointestinal hemorrhages to be treated without needing 
to be admitted to the hospital.
A new study, titled “Video Capsule Endoscopy in the 
Emergency Department: A Prospective Study of Acute 
Upper Gastrointestinal Hemorrhage,” published in Annals 
of Emergency Medicine, is the first to examine the use of 
capsule endoscopy by emergency physicians for suspected 
acute upper gastrointestinal bleeding.  
“Video capsule endoscopy performed by emergency 
physicians was very accurate and nearly universally toler-
ated by patients,” says lead author Andrew Meltzer, M.D., 
assistant professor of emergency medicine at GW’s School 
of Medicine and Health Sciences. “This is an example of the 
‘whiz-bang’ side of emergency medicine that has the poten-
tial to save the health care system a great deal of money by 
preventing the hospital admissions that are typically required 
for esophagoduodenoscopy, a procedure used to diagnose 
acute bleeding.”
Meltzer and his team enrolled 25 patients with suspected 
acute upper gastrointestinal hemorrhage in their pilot 
study. Capsule endoscopy was well tolerated by nearly all (96 
percent) of the patients and showed 88 percent sensitivity and 
64 percent specificity for the detection of fresh blood. There 
was 92 percent agreement between gastroenterologists and 
emergency physicians on test results. 
The current gold standard of care for patients with acute 
upper gastrointestinal hemorrhage is emergency esophagoduo-
denoscopy, performed almost exclusively by gastroenterologists 
on patients who are admitted to the hospital. In 2011, 236,000 
patients received the procedure in the hospital; they had an 
average hospital stay of four days, costing $23,549 per patient. 
By comparison, the average Medicare fee for the video capsule 
endoscopy is $750 per patient.  
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s a resident, it’s easy to get overwhelmed by the 
countless hours worked, the number of patients 
seen and treated, and the volume of informa-
tion digested. Christopher Bayne, M.D., knows 
all about trying to balance long hours and little 
sleep as a second-year resident at the George Washington 
University School of Medicine and Health Sciences (SMHS), 
without losing sight of what’s important and rewarding 
about his job. 
Bayne grew up not far from Washington, D.C., in Lake 
Ridge, Va. As a star athlete in high school, Bayne experienced 
a sports injury that first drew his interests toward medicine. “I 
suffered a pretty bad ankle fracture playing soccer. My doctor 
told me he thought I might walk with a limp,” he recalls. Bayne 
underwent two orthopedic surgeries, sidelining him for most 
of his freshman year. Despite the painful procedures during 
the ordeal, Bayne has fond memories of his surgeon. “In my 
mind, my surgeon was a miracle worker. Not only was I able to 
kick a soccer ball again, but I went on play lacrosse.” 
Initially, Bayne had no plans to pursue urology. He 
vividly recalls a grueling review session on genitourinary 
anatomy during his first year at Eastern Virginia Medical 
School (EVMS). “I remember saying to myself, ‘There is no 
way I’m going to become a urologist or even an obstetrician/
gynecologist,’ because the anatomy was so confusing and the 
problems were so complex,” he says. 
A resident’s Humanistic 
Approach to Medicine
by LAuRA OTTO
It wasn’t until Bayne met Joshua Logan, M.D., chief 
resident at EVMS, who would later become his mentor, 
that he decided urology was the right choice for him. 
“The urology program at my medical school ran a clinic 
for people who couldn’t afford health care. As part of my 
internal medicine rotation, I spent one day working with 
Dr. Logan treating homeless men and women with urology 
problems,” he says. Everything changed for Bayne after 
working one-on-one with Logan. 
Impressed by the cutting-edge robotics work going on 
in GW Hospital’s Urology Department, Bayne knew this 
was where he needed to be. For him, there was something 
different about residents training in an urban environment. 
Bayne had seen a da Vinci robotic procedure at other 
hospitals, where surgeons used the high-tech device to 
remove the prostate, but never with the level of profes-
sionalism he had witnessed at GW Hospital. “At the time, 
most medical schools using robotics were in the trial-and-
error phase, but at GW it had obviously been perfected,” 
he recalls.
Because a resident’s routine is so demanding, it’s easy to 
lose sight of what’s really important and rewarding about the 
job. “At the end of the day, everything you do impacts your 
patient directly,” Bayne says. “You can choose to go about it 
routinely or you can take a little extra time to get to know 
your patient and inject some kind of humanistic personalized 
care.” This is precisely why Bayne is currently leading the 
Arnold P. Gold Foundation’s new resident Gold Humanism 
Honor Society chapter at SMHS. The Gold Foundation 
is a nonprofit organization designed to bring humanistic, 
patient-centered care back at every level of health care. Bayne 
hopes SMHS will serve as a model for other medical schools 
to follow. Going forward, he plans to organize small events 
that interject a little humanism into the life of the residents. 
It could be something as simple as an essay contest with 
a humanistic theme. “We want to encourage residents to 
reflect on the elements of their job that they find rewarding,” 
he explains. 
“As a resident, you have demands coming from every 
corner,” Bayne continues. “Nothing can ever be done fast 
enough or efficiently enough, and it’s easy to get bogged 
down by the long hours and a heavy patient load.” For him, 
it’s about the small, personal things, taking five extra minutes 
to get a patient some fresh sheets and a pillow, for example. 
Even though it’s not typically a doctor’s job, it helps his 
patient sleep better. “Taking a little extra time to get to 
know your patient and incorporate some kind of humanistic 
personalized care gives your patient not only great medical 
care, but a great health experience,” says Bayne.   
A
resiDent profile
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ristin Ceniccola feels at home standing before a 
lab bench collecting and analyzing data for her 
latest research project. After all, it’s what she 
does best, and she has the award to prove it. 
Ceniccola, a third-year Ph.D. student in the 
Institute for Biomedical Sciences (IBS) and a research assis-
tant in the Department of Pharmacology and Physiology at 
the George Washington University School of Medicine and 
Health Sciences (SMHS), earned top honors at GW’s 2012 
Health and Medicine Research Day during her second year 
of doctoral studies, for her poster “The Glucagon Receptor 
Functions as a Tumor Suppressor That Is Lost in Advanced-
Stage Hepatocellular Carcinoma.” Research Day is an annual 
event at which students, faculty members, and residents 
present their medical research initiatives and compete for 
awards in posters and oral presentations. For Ceniccola, being 
named the oral presentation winner for IBS solidified the 
In the race for research
by LAuRA OTTO
notion that she was on the right track. “Receiving that honor 
meant that people were interested in the research I was 
conducting and that it was important enough to be presented 
to the academic community,” she recalls. 
Currently, Ceniccola works with Norman H. Lee, 
Ph.D., professor of Pharmacology and Physiology at SMHS, 
looking at a receptor in liver cancer that functions as a tumor 
suppressor. Until now, the receptor has been studied only in 
the context of metabolism because it plays a role in diabetes 
and other diseases that are not linked to cancer. Knowing 
that this receptor plays an important role in cancer devel-
opment, Ceniccola is exploring how she can best utilize or 
exploit it for potential treatments. 
Lee’s lab was a perfect fit for Ceniccola because it offered 
her the mix of cancer research and molecular biology that 
she couldn’t find in other labs, and Lee has also taken on a 
mentorship role for Ceniccola. “Dr. Lee is very involved in 
all the aspects of my projects,” says Ceniccola. “His door is 
always open if I have a question or need advice.” 
Ceniccola earned her bachelor’s degree in chemistry 
from Cornell University. Her first research job involved 
protein analysis of hydrogel particles. However, this type of 
research didn’t have the impact she was looking for, and it 
didn’t offer the amount of real-time bench science she craved. 
Ceniccola decided to transition to biochemistry. GW’s 
School of Medicine and Health Sciences caught her attention 
because the IBS Department offered a mix of studies: cancer, 
physiology, biology, and pharmacology. “I knew GW would 
give me experience in a variety of different areas in biological 
sciences,” she says. 
When she’s not in the lab, Ceniccola is pounding the 
pavement training for marathons. An avid runner, she sees a 
lot of similarities between pursuing a Ph.D. and training for 
a marathon, and running offers the perfect respite after hours 
in the lab. “I can take some time out of my day and go for a 
run and clear my head and think about things that need to be 
done in the lab or related to my projects,” she says. 
Ceniccola completed the 2012 Marine Corps Marathon 
in an impressive 3 hours and 42 minutes. For her, it is impor-
tant to find the right training plan to fit her busy schedule so 
that she can achieve optimal results both at the bench and on 
the pavement. “I like the way she approaches her marathon 
training, which has great parallels with how she conducts her 
research,” says Lee. 
Ceniccola says it’s important for medical students inter-
ested in pursuing research to keep their options open and be 
willing to explore different avenues of study. “Don’t be married 
to your hypothesis,” says Ceniccola. “Because you may end up 
finding something even more interesting and promising.”  
k
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His left hand in his father’s, his right clutching the black 
doctor’s bag, young Floyd Loop made the rounds with his 
dad on the rural farms of Lafayette, Ind. It seemed the 
right kind of life to the boy, the country doctor’s life. “I 
interacted with a lot of patients and I saw their appreciation 
and the gratification my father received,” he recalled seven 
decades later.
And he did become a doctor, but events conspired to pluck 
him from the pastoral setting of spending his career as a rural 
family doc, and led him to become one of the world’s leading 
heart surgeons and head of the renowned Cleveland Clinic.
As graduation ceremony speaker for the GW School 
of Medicine and Health Sciences (SMHS) class of 2013, 
Floyd D. Loop, M.D. ’62, will speak about the opportunities 
ahead for medical graduates. After graduating from Purdue 
University and GW Medical School in 1962, he received 
postgraduate surgical training at GW. He served in the 
United States Air Force at Andrews Air Force Base, and later 
pulling a prestigious Career from a 
Country Doctor’s Bag
The well-worn paths of a country doctor lead Floyd d. Loop, M.d. ’62, from rural Indiana to the 
center stage of cardiovascular surgery
by STEVE GOLDSTEIN
AlUmnUs profile
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trained in cardiothoracic surgery at the Cleveland Clinic. 
In 1971 Loop was appointed to the staff of the Cleveland 
Clinic. He became chair of the Department of Thoracic 
and Cardiovascular Surgery in 1975, a post he held until 1989 
when he was named chief executive officer of the Cleveland 
Clinic and chair, Board of Governors.
Floyd Loop has performed more than 12,000 open-heart 
operations and is the author of 350 papers on all aspects of 
cardiovascular surgery. During his 15-year tenure as chief 
executive, he led a reorganization of the clinic and enhanced 
its academics. Under his leadership, the clinic built new 
specialty and research buildings on campus and designed a 
new health delivery system by acquiring eight Cleveland-area 
hospitals and constructing an additional 14 outpatient clinics. 
The Cleveland Clinic Lerner College of Medicine, the first 
new U.S. medical school in 25 years, opened in 2002.
His experience in Washington, D.C., shaped his career. 
Unlike the modern digs of today, the medical school of 
Loop’s days at GW was housed in a Civil War-era building 
in the 1300 block of H St., N.W. “I liked to go to the old 
bookstores and browse for hours,” he recalls. “You could walk 
everywhere. My roommates and I lived in northern Virginia 
and I had an old Vespa motor scooter we used to get to class. 
I remember seeing Vice President Richard Nixon, who was 
being driven to ‘work.’ He always waved to us. Washington 
was a real sleepy town then.”
Following his second year, Loop started his rotation 
through the various services and quickly took a liking to 
surgery. This brought him into contact with Brian Blades, 
M.D., the former Lewis B. Saltz Chair of Surgery. “The 
surgeons on his staff were superb, and they were excellent 
teachers,” says Loop. In return for a draft deferment to finish 
his residency, Loop agreed to serve in the Air Force. Blades 
arranged for Loop to serve at Andrews Air Force Base, where 
he gained surgical experience. “I got a year’s credit on my 
residency and returned to GW to complete my residency,” 
Loop says.
After completing his third year of training, Loop sought 
out Blades and related his intended plans. “He listened 
patiently and then he said, ‘No, you’re going to the Cleveland 
Clinic,’ ” Loop remembers. “His first resident, Don Effler, 
M.D., ran the program there. Blades said things were changing 
in cardiac surgery and Effler and his staff were in the forefront. 
I took his advice and that was a defining moment.”
Loop gained an international reputation as a heart 
surgeon. He assembled a group of skilled and experienced 
thoracic and cardiovascular surgeons who helped enhance the 
clinic’s reputation. Loop and his colleagues were responsible 
for today’s widespread use of arterial conduits in coronary 
artery surgery, innovations in valve repair, and pioneering 
technical improvements for re-operations.
Under his leadership, the Cleveland Clinic rose to be 
ranked consistently in the 10 top hospitals in the United 
States. “He had a solid vision for growth for the clinic’s 
health system,” current CEO Delos Cosgrove, M.D., told 
Crain’s Cleveland Business. “He pushed the organization in 
the right direction that was fundamental to achieving our 
current status.”
Loop says he foresees further innovations in heart 
surgery for less invasive surgery. Today he serves on public 
and private corporate boards. In 2009, he published a book, 
titled Leadership and Medicine. “I think physicians should lead 
health care institutions,” he explains. “They can talk to fellow 
doctors better than business people can, and they can always 
learn business fundamentals.”
Orchids, gardening, and orchards form Loop’s horticul-
tural passions. His constant companions are a pair of golden 
doodles named Lewis and Clark. He also keeps in close 
contact with his four daughters. He was married for 25 years 
to cardiologist and former National Institutes of Health (NIH) 
Director Bernadine Healy, M.D., who died in August 2011. 
“We kept an apartment in Washington when she was at NIH 
and the Red Cross, but she came home to Cleveland every 
weekend,” he says. Healy was the first woman to lead NIH.
Loop says he once imagined himself as a civil engi-
neer, but that career path was “always a distant second.” 
His father’s experience was instructive — and seductive. 
Nevertheless, the boy clutching his country doctor father’s 
black bag, dreaming of a life of bucolic medicine — “deliv-
ering babies, fixing hernias, making house calls” — got a little 
sidetracked. “Those were good days, and they gave me some 
incentive,” Loop says. Doubtless, those residents of rural 
Indiana who may rue the loss of a young practitioner, but will 
admit Loop’s heart was always in his work.  
under his leadership, the Cleveland Clinic 
rose to be ranked consistently in the 10 
top hospitals in the united States. Loop 
was named one of 30 persons who made 
the greatest contributions to Cleveland in 
the past 30 years. 
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SMHS Alumnus 
Richard Popiel 
Awarded the 
2013 Alumni 
Outstanding 
Service Award
Richard Popiel, CCAS B.A. 
’75; SMHS M.D. ’81, G.M.E. 
’83; and member of the GW 
Alumni Association’s board of directors, representing the 
School of Medicine and Health Sciences, was awarded the 
2013 Alumni Outstanding Service Award on Apr. 18. Not 
only does Popiel lend a balanced voice on important issues 
pertaining to GW, but he is working to raise more than 
$100,000 to endow a scholarship for the M.D. class of 1981. 
Last fall, Popiel was invited by GW President Steven Knapp 
to present on the topic of health care management and lead-
ership at the president’s reception in New York on Oct. 23.
As a leading expert on health care management, Popiel 
was recently named senior vice president, health care 
services, and chief medical officer for all of the Regence 
Group’s health insurance plans. In this role, Popiel leads 
medical strategy and provides executive leadership on 
addressing care initiatives and cost management. 
Prior to joining the Regence Group, Popiel served as 
president and chief operating officer of Horizon Healthcare 
Innovations. Under his leadership, Horizon Healthcare 
Innovations launched more than 30 pilot programs involving 
80,000 members, such as medical home projects and 
accountable care organization partnerships. These accom-
plishments, which improved health outcomes while curbing 
costs, are cited as effective industry case studies.
He has held leadership positions for key organizations 
throughout his career. Popiel served as vice president and 
chief medical officer at Horizon Blue Cross Blue Shield 
of New Jersey, was a member of the board of directors of 
Horizon Healthcare of New Jersey, and was the chair of the 
National Council of Physician and Pharmacist Executives, 
among other notable roles.
In addition to his degrees earned at GW, he holds an 
M.B.A. from Northwestern University. Popiel lives with his 
wife in Portland, Ore. Their two sons are current undergrad-
uates at GW.  
Sogani Ascends to American  
Urological Association Presidency
Pramod C. Sogani, M.D., G.M.E. ’71, FACS, FRCS, a 
urological oncologist and attending surgeon at Memorial 
Sloan-Kettering Cancer Center (MSKCC), assumed the presi-
dency of the American Urological Association (AUA). The 
110-year-old association is the premier professional associa-
tion for the advancement of urologic patient care.
Sogani served as president-elect from May 2012 until 
the AUA annual meeting in San Diego, May 8, 2013. 
Previously he served as treasurer, president, and represen-
tative to the board of directors for the New York section 
of the AUA. He was the recipient of the Sasruta Award of 
Excellence in Urology of the Indian American Urological 
Association, the John K. Lattimer Award of Excellence 
in Urology of the Kidney Foundation of America, the 
Distinguished Service Award of MSKCC, the Award of 
Distinction of Weill Cornell Medical College, and the 
Russell W. Lavengood Distinguished Service Award of the 
New York section of the AUA.   
ClAss notes
1960s
lEONARD WARtOFSKY, M.D. ’64, B.S. ’59, received the 
2012 Robert H. Williams Distinguished Leadership Award of 
the Endocrine Society. In 2011, Wartofsky received the GW 
Distinguished Alumnus Award. He is also editor-in-chief of 
The Journal of Clinical Endocrinology & Metabolism.
MARilYN RENFiElD, M.D. ’65, G.M.E. ’66, GW assistant 
clinical professor of psychiatry and behavioral science, 
received the Elaine W. Cotlove, M.D. Award for Excellence 
in Psychiatric Education.
1970s
BRiAN SCHulMAN, M.D. ’71, B.A. ’68, was named to 
Washingtonian Magazine’s Top Doctors 2012 edition for psychiatry.
ROBERt BRANSFiElD, M.D. ’72, recently published the 
following journal articles: “Can Infections and Immune 
Reactions to Them Cause Violent Behavior?” in the 
Proceedings of the 11th Psychoimmunology Expert Meeting, 
Gunzburg, Germany, March 10, 2012, Neurology, Psychiatry, 
and Brain Research, 18(3); “Relationship of Inflammation and 
Autoimmunity to Psychiatric Sequelae in Lyme Disease,” 
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Psychiatric Annals, 42(9), 337-341; “The Psychoimmunology 
of Lyme/Tick-Borne Diseases and its Association with 
Neuropsychiatric Symptoms,” The Open Neurology Journal, 
6 (Suppl 1-M3), 88-93; and “Long Term Antibiotic Therapy 
May Be an Effective Treatment for Children Co-Morbid with 
Lyme Disease and an Autism Spectrum Disorder,” with Kuhn 
et al., Medical Hypotheses, 78(5), 606-615.
GEORGE KORENGOlD, M.D. ’72, was named to 
Washingtonian magazine’s Top Doctors 2012 edition 
for pediatrics. Korengold was also named the 2012 
Montgomery-Prince George’s County Pediatric Society’s 
Pediatrician of the Year. 
DAViD KEStENBAuM, M.D. ’74, a gastroenterologist with 
Kaiser Permanente in Fontana, Calif., will retire after nearly 
40 years of practice. He served as chief of the division of 
gastroenterology for 22 years at Kaiser.
AlAN SAGER, G.M.E. ’76, GW associate clinical professor 
of Psychiatry, was named to Washingtonian magazine’s Top 
Doctors 2012 edition for psychiatry.
DONAlD W. AllEN, M.D. ’77, adjunct associate professor of 
family and preventive medicine, University of Utah School 
of Medicine, received the 2012 Outstanding Teacher Award, 
University of Utah Physician Assistant program. In addi-
tion to holding his faculty position, Allen serves as medical 
director for both Park City Medical Center, and Utah and 
Idaho — Encompass Home Care and Hospice.
DAlE H. iSAACSON, M.D. ’77, G.M.E. ’81, was named 
to Washingtonian magazine’s Top Doctors 2012 edition 
for dermatology.
BARBARA SNYDER, M.D. ’79, associate professor of medi-
cine and chief of the Division on Adolescent Medicine at 
Robert Wood Johnson School of Medicine, was named a 
“Best Doctor” by New York Magazine for 2012. It marks the 
fifth consecutive year Snyder has made the list.
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ClAss notes
Kassan Masters 
Rheumatology
Stuart Kassan, M.D. ’72, 
member of the George 
Washington University 
board of trustees repre-
senting the School of 
Medicine and Health 
Sciences, was awarded 
the title of master by 
the American College of 
Rheumatology (ACR) during the November 2012 ACR 
Annual Meeting, in Washington, D.C.
The distinction is conferred by the board of directors 
of ACR, for those members who have made outstanding 
contributions to the field of rheumatology through schol-
arly achievement and/or service to their patients, students, 
and profession. 
Kassan serves as chief medical officer with Aspire 
Behavioral Health in Denver and has served as a clinical 
professor of Medicine at the University of Colorado Health 
Sciences Center since 1994. He also currently practices at the 
Colorado Arthritis Associates in Lakewood, Colo.  
Health Care  
Humorist
John F. Hunt, M.D. ’92, associate 
professor at the University of 
Virginia, and co-founder of the 
Trusted Angels Foundation — a 
nonprofit organization that works for 
children in Liberia, West Africa — 
recently published Assume the Physician, 
a satirical novel about the current 
health care system and the causes of 
medical hyperinflation.  
1980s
KEViN MiCHAEl Gil, M.D. ’80, was named to 
Washingtonian magazine’s Top Doctors 2012 edition for 
family medicine/geriatrics.
JANE BENiNG, M.D. ’81, was the featured speaker at the 
Vibrantly You Women’s Wellbeing Symposium, La Costa 
Hotel and Spa, Carlsbad, Calif., in January 2013.
1990s
RAJ GOYAl, M.D. ’93, B.S. ’89, recently served as the 
primary investigator in pivotal clinical trials of iStent.
KAREN AltON, M.D. ’95, was voted a Southeast Michigan Top 
Doc in Adolescent Health for 2012 by www.hourdetroit.com.
DOMiNiquE HOWARD, M.D. ’97, G.M.E. ’00, GW assistant 
clinical professor of medicine, was named to Washingtonian 
magazine’s Top Doctors 2012 edition for gastroenterology. 
Howard was also elected to serve as president of the William 
Earl Clark Society.
2000s
tHERESA JERuSSi, M.S. ’00, was recently appointed as an 
adjunct faculty member of GW’s Physician Assistant program.
iAN W. MARKS, M.S. ’00, wrote the chapter “Spine” for 
the textbook Orthopaedics for Physician Assistants (Elsevier), 
published April 2013. Lt. Marks, U.S. Coast Guard, recently 
returned from deployment to CENTCOM as a medical 
officer supporting Operation Enduring Freedom and 
Operation New Dawn.
DAVE BRiGHt, M.D. ’01, is the teaching attending physician 
at Mercy Medical Center, and assistant professor of medicine, 
University of Maryland School of Medicine.
tHOMAS W. SORBER, M.S. ’01, was named chair of the 
Physician Assistant Executive Committee at University of 
Rochester Medical Center.
ERiC WOlliNS, M.D. ’02, was named a 2013 “Top Doctor” 
in gastroenterology by Northern Virginia Magazine, and was 
named among the 2013 “Super Doctor Rising Stars” by the 
Washington Post Magazine. 
JEFFREY ANDERSON, M.S. ’07, board-certified pharmaco-
therapy specialist, was named system director of pharmacy 
services for Yavapai Regional Medical Center — Prescott and 
Prescott Valley, Ariz.
KAREN BuiKEMA, M.S. ’08, received the 2013 Marquette 
University College of Health Sciences Alumni Award for 
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o  Do you have property that is a burden to manage? 
o  Do you own property you don’t use anymore? 
o  If you sell a property, will you owe significant taxes?
If so, GW can help. By donating real estate to GW,  you can achieve peace 
of mind, create a lasting legacy in support of the university and receive 
financial benefits for yourself or someone else.
What’s in it for you?
Depending on the nature of your gift and your objectives, you could:
	 •	Avoid	capital	gains	taxes	on	appreciated	property
	 •	Eliminate	the	burden	of	maintaining	and	paying	for	the	property
	 •	Provide	yourself	with	an	annual	income
	 •	Continue	to	use	the	property	for	the	remainder	of	your	life
	 •	Reduce	your	estate	and	income	taxes
	 •	Help	the	program	of	your	choice
GW accepts many types of property including residential and  
commercial property, and undeveloped land.
JU
ST
 GI
FT
ED
The George Washington University
Office	of	Planned	Giving	–	Real	Estate
2100 M Street, NW, Suite 310
Washington,	DC	20037
For more information, please contact 
Chase Magnuson, Director of Planned 
Giving for Real Estate at  202-994-4979 
or chasem@gwu.edu. 
Do	You	Own Property?
DAR1762
ClAss notes
New job? publication? Change of address? Share your news. please send your Class Notes to: Email, smhsalumni@gwu.edu, 
call (202) 994-7511, or log on to smhs.gwu.edu/alumni/update-form
Professional Achievement. In 2010, Buikema received the 
United States Air Force Medical Service Clinical Laboratory 
Manager of the Year award.
JAClYN AlBiN, M.D. ’09, will serve as pediatric chief resident 
at Texas Children’s Hospital for the 2013–14 academic year.
tHOMAS JOSEpH MARuNA, B.S. ’09, who passed the 
United States Public Health Service boards and was 
commissioned in April 2013, has been promoted to hospital 
administration, focusing on quality assurance.
MiNDY DitCH, M.S. ’10, was recently promoted to clinical 
project manager at St. Jude Medical, where she manages a 
pediatric heart valve clinical trial.
ANDREW H. GORDON, M.D. ’10, was elected president 
of the Resident Physician Council Board of the American 
Academy of Physical Medicine and Rehabilitation (AAPM+R) 
for 2012–13; serves on the AAPM+R Board of Governors for 
2012–13; and was accepted to the pre-application phase of the 
Rehabilitation Medical Scientist Training Program. 
tOMMY lEE, M.S. ’11, published the article “Spray-applied  
Cell Therapy with Human Allogeneic Fibroblasts and 
Keratinocytes for the Treatment of Chronic Venous Leg 
Ulcers: a Phase 2, Multicentre, Double-blind, Randomised, 
Placebo-controlled Trial,” in The Lancet, 2012; 380, 977-985.
SHilpA AGARWAl, M.D. ’12, B.A. ’08, completed her 
residency in family medicine, and is board certified in both 
family medicine and integrative and holistic medicine.
REHAN M. HuSSAiN, M.D. ’12, B.A. ’08, ophthalmic 
pathology fellow for 2012–13 at Bascom Palmer Eye Institute, 
recently matched into an ophthalmology residency program 
at Indiana University (beginning July 2014).
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ClAss notes
In Memoriam
GAEtANO MOliNARi, M.D., former chair of neurology at GW’s 
School of Medicine and Health Sciences (SMHS), died Dec. 14, 2012, after 
a long illness. He was 76 years old. In the early 1970s, Molinari was the 
head of stroke research at the National Institutes of Health; he joined the 
SMHS faculty in 1976. Molinari retired in 1994, but he continued lecturing 
as a clinical expert on stroke for many years afterward. He was a member 
of Alpha Omega Alpha, a former captain in the U.S. Air Force, and a 
Vietnam veteran.
Alumni 
PHILIP J. BALesTrIerI, M.d. ’87
PHILIP T. BAnd, M.d. ’45
JoHn G. BATsAkIs, M.d. ’55
ZALe P. BernsTeIn, M.d. ’80
HerBerT e. BLock, M.d. ’40
AnITA M. BoscH, PA ’00
nAncy Bruckner, M.d. ’76
rIcHArd G. cALL, M.d. ’60
BeTH Ann coLLIns, M.d. ’70
rIcHArd M. cooPer, M.d. ’66
Jere JAck dAuM, M.d. ’57
HAroLd A. dAvIs, M.d. ’45
roBerT M. deLIMAn, M.d. ’53
FrAnk denAro, M.d. ’63
dAvId A. deWs, cerT ’08
dAvId GeorGe dIxon, M.d. ’57
PAuL A. dorn Jr., M.d. ’70
roBerT L. GreenLee, M.d. ’49
MArIe A. HAnAcHe, M.d. ’57
ForesT k. HArrIs, M.d. ’53
roBerTA kATLAn HeLFGoTT, M.d. ’72
JAMes e. JAckson, M.d. ’59
ALLen L. kAuFFMAn, M.d. ’62
GIdeon MusyIMI kIoko, M.d. ’73
dAvId ALAn LIncoLn, M.s. ’04
J. dAvId LIneHAn, G.M.e. ’79
LAWrence c. MArceLLA, M.d. ’55
deBrA s. McMAHAn, M.s. ’01
HerBerT A. MILLer, M.d. ’61
ALBerT J. ModLIn, M.d. ’54
rIcHArd H. MoTT Jr., M.d. ’50
JoHn P. nAuGHTon, M.d. ’59
GerALdIne W. PAuL, M.d. ’64
donALd k. PIne, M.d. ’52
MeLvIn A. PorTer, M.d. ’49
JoHn e. PrIcHArd, M.d. ’48
JAMes MArk roGers, A.s. ’81
AsHLey Ann soBcZAk, cerT ’05
c. HerBerT sPencer, M.d. ’50
ryAn BAccus squIres, cerT ’05, A.s. ’07
donALd sTuBBs, M.d. ’32
kenneTH c. sZe, M.d. ’43
WILLIAM F. THoMPson, M.d. ’67
H. roBerT unGer, M.d. ’52
WArren e.c. WAcker, M.d. ’51
FRANK MillER, M.D. ’48, B.S. ’43, 
professor emeritus of pathology at GW’s 
School of Medicine and Health Sciences 
(SMHS), passed away April 24, 2013. 
“As a professor, mentor, and friend, 
Dr. Miller was one of the most beloved 
faculty members in the history of GW’s 
School of Medicine and Health Sciences, 
and he will be missed by so many within 
our community,” said Jeffrey S. Akman, 
M.D. ’81, G.M.E. ’85, vice president for 
health affairs and dean of SMHS.
Miller’s dedication and influence as a teacher, shaping the future 
careers of generations of medical students from 1944 until his retirement 
in 1985, earned him GW’s Distinguished Teacher Award in 1998. Because 
of his ability to connect with students and mentor residents and fellows, he 
was GW’s first recipient of the “Golden Apple” award, presented to him for 
excellence in teaching the basic sciences. By the time Miller retired, he had 
been awarded seven such prizes — an unprecedented total at the time.
Miller was embedded in the cultural fabric of GW. His legacy will 
live on through the Dr. Frank N. Miller Endowed Professorship, which 
supports a distinguished teaching professorship in SMHS, and the Dr. 
Frank Miller Award, given annually to a pathology resident or fellow in 
recognition of excellence in teaching.
Miller is survived by his wife, Caroline Sykes Miller; son, Donald 
Miller; and daughter, Catherine Sluder, manager of the Bloedorn 
Technology Center in GW’s Himmelfarb Health Sciences Library.
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in DeVelopment
if you are interested in supporting any of the initiatives featured in this magazine, visit www.gwu.edu/give2gw
he George Washington University School of Medicine and 
Health Sciences (SMHS) is making great strides in its mission 
of education, patient care, and research. In these pages, you’ll 
find many stories about SMHS programs of excellence that are 
elevating GW’s reputation and changing the face of medicine.
Achieving our goals requires major financial investments, 
and we invite our community to help us. Philanthropy has never been more 
important. In addition to outright gifts, there are a number of creative and 
sophisticated methods of giving that can result in substantial tax and finan-
cial advantages to donors. For example, GW has a very active real estate 
donation program. SMHS accepts a broad range of real estate gifts, subject to 
approval by the GW gift acceptance committee. Some examples are below.
•  Second homes, including beach condos, mountain cabins, or ski chalets 
that are no longer in use by family members, can constitute excellent 
donations.
•  Medical office suites or complexes that house a practice that is being sold 
can be donated. By contributing the real estate and selling the practice, 
the donor can create a meaningful legacy at the school.
•  Rental properties that have management difficulties or low rates of 
return might effectively be used to fund a lifetime income stream for the 
donor, which can be guaranteed by GW in some cases.
Additionally, donors who are age 70 1/2 and older may now contribute 
up to $100,000 tax-free directly from their IRA; however, this opportunity 
expires on Dec. 31, 2013.
GW’s development professionals are knowledgeable about these topics. 
Please remember SMHS in your philanthropy plans and contact the Office of 
Development and Alumni Relations, with no obligation, if you desire further 
insight and information on these and other methods of giving. 
Thank you,
Dennis Narango, M.A., C.F.R.E.
Associate Dean, SMHS and Associate Vice President for GW Medicine 
Development and Alumni Relations
email: dnarango@gwu.edu
phone: (202) 994-7511
investing in the Future of Medicine
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JuMPInG To soLuTIons
researcher sally Moody uses frog embryos to clear the knowledge 
gap in neural regeneration .  read more on page 14
